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Abstract  
 
Three-dimensional (3D) thermoplastic polyurethane/polystyrene blend (TPU/PS 
wt% 90/10) porous scaffolds were fabricated via supercritical carbon dioxide 
combined with solvent etching for tissue engineering application. The 
microstructure, physical properties, cell proliferation on the 3D TPU/PS blend 
porous scaffolds and in vitro controlled release behavior of aspirin coated on the 
3D TPU/PS blend porous scaffolds were investigated by scanning electron 
microscope, compression test, permeability assessment, biological assay and in 
vitro release assessment. TPU and PS are immiscible and there are two phases in 
3D TPU/PS blend porous scaffolds which are TPU rich phase and PS lean phase. 
The microstructure and physical properties depend on the dissimilar solubility of 
scCO2 in 3D TPU/PS blend porous scaffolds via different disposal parameters such 
as venting time, temperature, soaking time and pressure. The interconnectivity of 
3D TPU/PS blend porous scaffolds was improved via solvent etching to remove 
PS particles from PS lean phase while maintaining the mechanical strength of 
scaffolds. The cell proliferation on the 3D TPU/PS blend porous scaffolds and in 
vitro sustained release profile of aspirin coated on the 3D TPU/PS blend porous 
scaffolds before and after solvent etching were significantly affected by 
microstructure of 3D TPU/PS blend porous scaffolds for example pore size, 
porosity and interconnectivity. The present study demonstrates: (1) TPU and PS 
are immiscible and there are two phases in 3D TPU/PS blend porous scaffolds 
 IX
which are TPU rich phase and PS lean phase; (2) 3D TPU/PS blend porous 
scaffolds can be fabricated via scCO2 technology and the microstructure of 3D 
TPU/PS blend porous scaffolds can be tailored by careful control of scCO2 
processing parameters; (3) the interconnectivity of 3D TPU/PS blend porous 
scaffolds can be improved via solvent etching to remove PS particles from PS lean 
phase meanwhile the mechanical strength of 3D TPU/PS blends porous scaffolds 
can be maintained; (4) fibroblast proliferation on 3D TPU/PS blend porous 
scaffolds and in vitro release behavior of aspirin form 3D TPU/PS blend porous 
scaffolds are influenced by the microstructure of TPU/PS blend scaffolds. These 
results indicate that scCO2 combined with solvent etching is a new technology to 
fabricate 3D TPU/PS blend porous scaffolds and TPU/PS blend scaffolds with 
improved interconnectivity. The 3D TPU/PS blend porous scaffolds possessing 
suitable pore size and porosity with improved interconnectivity can potentially be 
used as a candidate matrix in tissue engineering application.  
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CHAPTER ONE 
 
1 Introduction 
 
Porous 3D polymeric scaffolds have attracted increased attention in regenerative 
medicine and TE in recent years because they are able to provide mechanical 
properties matching tissue at the implantation site or mechanical properties that 
protect cells from outside damaging compression [1]. Additionally, polymeric 
scaffolds can be custom made to support cell adhesion and proliferation, facilitate 
cells to cells contact and signal transmission, cell migration and assist in tissue 
formation [1]. Numerous approaches to fabricate 3D porous scaffolds for tissue 
engineering applications such as scaffold moulding, gas foaming, particle leaching, 
textile technologies, emulsification/freeze drying, liquid-liquid or liquid-solid 
phase separation, electrospinning, solid freeform fabrication, foaming agent, 
solvent casting and lithography have been reported in the literature. [1]. However, 
the main drawbacks of these methods are lack of interconnectivity, the use of 
toxic chemical solvents, poor mechanical strength and limited control of pore size 
[1].  
 
A technique utilising scCO2 has the potential to overcome these limitations. scCO2 
is an inexpensive, non-toxic and non-flammable gas that is available in high 
purity from a variety of sources. Above the critical temperature and pressure (Tc = 
 2
31.1 oC, Pc = 73.8 bar), scCO2 demonstrates the unique properties of combined 
gas-like diffusivity and liquid-like density [1, 2 - 17]. These unique properties of 
scCO2 can be used as processing medium for the production of either fine 
particles or to function as a porogen in the production of porous foams without 
using chemical solvents [1, 2 - 17]. Recently, a number of studies have reported 
using various types of polymer such as poly(DL-lactic acid), 
poly(lactic-co-glycolic acid), poly(caprolactone), polystyrene, poly(methyl 
methacrylate), poly(ethylene terephthalate), and polymer blend of poly(ethyl 
methacrylate) and tetrahydrofurfuryl methacrylate to fabricate 3D scaffolds via 
scCO2 [1, 2 - 17]. However, the shortcomings of scaffold fabricated via scCO2 are 
the lack of interconnectivity and a non-porous surface. Particle leaching method 
was introduced to address these problems [1, 2 - 17]. Although particle leaching 
processing could improve the interconnectivity of scaffolds, it was limited to 
non-degradable scaffolds as exposure to water and/or humid environment would 
result in degradation and loss mechanical properties of biodegradable scaffolds 
prior to their applications [1]. This thesis hypothesised that the use of scCO2 
combined with solvent etching, namely, utilising properties of materials with 
diverse solubility in different solvents, can address this issue. 
 
A polymer of interest is TPU as it has been widely used as scaffolds for artificial 
skin, cardiovascular implants, nerve conduits, cancellsous bone graft substitutes 
and articular cartilage repair. [18 - 26]  The fabrication techniques that are 
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commonly used include solvent casting/particle leaching, electrospin, inkjet, salt 
leaching/freeze-drying and TIPS. Thus far, there has not been research focusing 
on TPU scaffolds fabricated via scCO2 combined with solvent etching to improve 
permeability for TE application. 
 
1.1  Research Motive 
  
As mentioned above, high porosity and inter-connected pore structures are 
essential properties of 3D porous scaffolds [1, 27]. The ability to fabricate 3D 
porous scaffold with improved interconnectivity while maintaining the desired 
mechanical properties is a continual research focus in the field of tissue 
engineering [1]. Therefore, the overall objective of this study is (1) to fabricate 3D 
TPU/PS blend (90/10 wt%) porous scaffolds via scCO2 with a variety of 
processing conditions such as VT, T, ST, and P; two phases, a TPU-rich phase and 
a PS-lean phase, were observed in the 3D TPU/PS blend porous scaffolds due to 
the different chemical properties of these two polymers; (2) to improve the 
interconnectivity of 3D TPU/PS blend porous scaffolds fabricated by scCO2 using 
solvent etching to remove PS particles from PS lean phase by use immiscible and 
phase separation properties of TPU and PS in 3D TPU/PS blend porous scaffolds. 
(3) biological properties of 3D TPU/PS blend porous scaffolds with different 
microstructures were assessed before and after solvent etching. Finally, in vitro 
controlled release behavior of aspirin coated 3D TPU/PS blend porous scaffolds 
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with a variety of microstructures was characterised before and after solvent 
etching. 
 
1.2  Methodology 
 
The recent developments of 3D porous scaffolds for biomedical applications are 
reviewed in detail in chapter two. In this chapter, three critical factors of 3D 
porous scaffolds for biomedical applications, (the type of polymeric material, cell 
source and scaffold fabrication methods) are summarized. The applications and 
current issues of 3D porous scaffolds in biomedicine are reviewed as well. 
 
Chapter three described the characterization of 3D TPU/PS blend porous scaffolds 
fabricated via scCO2 technology. Different processing parameters such as VT, T, 
ST and P were examined. The relationship between various scCO2 processing 
conditions and physical properties such as pore size, porosity, density and 
mechanical modulus of 3D TPU/PS blend porous scaffolds were discussed in this 
chapter.  
 
One issue encountered in chapter four, the need to improve the interconnectivity 
of 3D TPU/PS blend porous scaffolds, was addressed in this chapter. Solvent 
etching was used to remove PS particles from PS lean phase in 3D TPU/PS blend 
porous scaffolds for enhanced interconnectivity. The morphology, permeability 
 5
and mechanical properties of porous 3D TPU/PS blend porous scaffold before and 
after solvent etching were investigated.  
 
The aim of chapter five was to investigate the biocompatibility of 3D TPU/PS 
blend porous scaffolds. The cellular interactions of fibroblast cells on 3D TPU/PS 
blend porous scaffolds with different pore size, porosity and interconnectivity 
before and after solvent etching was investigated. Additionally, the effect of 
microstructures of 3D TPU/PS blend porous scaffolds on fibroblast cells 
proliferation was discussed.   
 
Finally, chapter six illustrated how 3D TPU/PS blend porous scaffolds after 
solvent etching can be used as a controlled release matrix in tissue engineering 
application. In this chapter, aspirin with different concentrations were coated onto 
3D TPU/PS blend porous scaffolds with different pore size, porosity and 
improved interconnectivity after solvent etching. The in vitro controlled behavior 
of aspirin coated onto 3D TPU/PS blend porous scaffolds was investigated and the 
influence of microstructure of 3D TPU/PS blend porous scaffolds on controlled 
release was discussed. 
 
The main conclusions of this study were summarized in chapter seven followed 
by discussions for some recommendation future research.  
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CHAPTER TWO 
 
2 Literature Review 
 
2.1  Tissue Engineering 
 
Organ dysfunction is one of the leading causes of death in the world. Organ 
transplantation offers a promising solution for patients with organ dysfunction [28 
- 34]. However, there are many disadvantages in organ transplantation such as 
shortage of suitable donor, life-long immunosuppressant therapy and high cost [28 
- 34]. The limitations of organ transplantation stimulate scientist to find 
alternatives to save patients’ lives and/or improve their life quality. This lead to 
the emergence of a multidisciplinary research field, tissue engineering also are 
referred to as regenerative medicine [28 - 34].  
Tissue engineering combines the principles of materials science, engineering, 
chemistry, physics and life science to fabricate biological substitutes similar with 
natural ECM that can maintain, restore and replace damaged or dysfunctional 
organ in the human body (Figure 2.1) [28 - 34]. In brief, one way of achieving this 
is by fabricating 3D porous tissue engineering scaffolds seeded with cells, growth 
factors or protein then scaffolds will be implanted to damaged tissue to replace, 
augment and restore the function of damaged tissue (Figure 2.2) [28 - 34].  
 7
         
Figure 2.1. Illustration of tissue engineering application in biomedicine, adapted 
from Ref. [29] with modification. 
The optimal strategy for any tissue engineering application involves the following 
steps [28 - 34]:  
(1) Choice or synthesis optimal materials such as polymer, metal and 
ceramic materials with desirable biocompatibility, biodegradability and 
mechanical properties that match with local tissue;  
(2) Fabrication 3D porous scaffolds with desirable technologies with 
suitable microstructure such as pore size, porosity and interconnectivity; 
(3) Isolate, identify and culture cells of target tissue and/or stem cells in 
sufficient amount;  
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(4) Seeding the cells on 3D porous scaffolds and undergoing pre-expansion 
in vitro; 
(5) Implant and/or transplant cell-seeded 3D porous scaffolds into the 
damaged area; 
(6) Cells seeded on 3D porous scaffolds secretes their own ECM and 
vascularised; 
(7) The degradation of 3D porous scaffolds over time and regeneration of 
host tissue to replace the scaffolds. 
 
Figure 2.2. Illustrate of 3D porous scaffolds application in biomedicine, adapted 
from Ref [109] with modification. 
As mentioned above, biomaterials, technology of 3D porous scaffolds fabrication 
and cell source are three important components in tissue engineering scaffolds 
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application. General description of materials of tissue engineering, technology of 
scaffold fabrication, cell source, application of scaffolds in tissue engineering and 
current issue of tissue engineering scaffolds are presented at the following parts.  
2.2  Materials for Tissue Engineering 
 
Although metal, ceramic and polymer materials have long history in biomedicine 
and/or tissue engineering application, the objectives of this part focus on 
polymeric materials including non-degradable, degradable and nature polymeric 
materials. General description of non-biodegradable, biodegradable and natural 
polymeric materials and their application in tissue engineering are presented in 
this part. 
 
Polymeric materials have been widely used in biomedicine and/or tissue 
engineering for many years such as disposable supply, prosthetic materials, dental 
materials, implants, wound dressings, extracorporeal devices, encapsulants, drug 
delivery systems, tissue engineered products, and orthodoses [35, 36]. Compared 
with metal and ceramic materials, the main advantages of polymeric biomaterials 
are the ease of fabricating various forms such as latex, film, 3D porous scaffolds, 
sheet and fibers, ease of processing, lower cost, and adjustable mechanical and 
physical properties [35, 36].  
 
Thousands of non-degradable and biodegradable polymeric materials are 
 10
synthesized and can be used as candidates for biomedical applications, only ten to 
twenty polymeric materials have been approved by FDA (USA) to be used in 
biomedical and/or tissue engineering devices from disposable to long-term 
implants due to their bio-safety [1, 35 - 37]. 
 
Non-degradable polymers such as PE, PP, PTFE, PDMS and PEO and so on have 
also been used to orthopaedic implants, catheters, bone cement, ocular lens, heart 
valves, and vascular graft for a long time [37]. Some of the commonly used 
non-degradable polymers, along with their name, chemical structure and 
application in biomedical and tissue engineering are listed in Table 2.1. 
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Biodegradable polymers such as PLA, PGA and their copolymer PLGA, 
poly(dioxanone), poly(trimethylene carbonate), poly(carbonate) and so on have 
also been used to fabricate 3D scaffolds, foam, vehicle for drug delivery, 
resorbable suture and filler of orthopaedics due to their excellent biocompatibility, 
biodegradability, non-toxic degradable product and ease of processing [35, 36, 38 
- 45]. Some of the commonly used biodegradable polymers, along with their 
chemical structures and tissue engineering applications are presented in Table 2.2 
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Table 2.2. Biodegradable Polymeric Materials as Biomaterials 
 
 
 
Biodegradable 
Polymeric materials 
Chemical Structure Application in biomedicine 
and tissue engineering 
Poly(β-malonic acid) 
O CH2 C
O
n  
Controlled release system 
Poly(tartronic acid) 
O CH 
COOH
C
O
n
Controlled release system 
Poly(valerolactone) 
O (CH2)4 C
O
n
Drug delivery 
Poly(3-hydroxyvalerate) 
O CH
C2H5
CH2 C
O
n
Controlled release 
Poly(3-hydroxybutyrate)
O CH CH2 C
O
n
CH3
Controlled release 
Poly(glycolic acid) 
O CH2 C
O
n
Porous 3D scaffolds, foam,
resorbable suture 
Poly(lactic acid) 
O C
O
n
CH3
CH
 
Porous 3D scaffolds, foam, 
resorbable suture 
Poly(glycolic-co-lactic 
acid) O C
O
n
CH3
CHCH2 CO
O Porous 3D scaffolds, foam, 
resorbable suture 
Poly(dioxanone) 
O
n
CH2 CO(CH2)2
Monofilament suture 
Poly(caprolactone) 
O
n
C
O
(CH2)5
 
Long-term drug/vaccine 
delivery vehicle 
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Natural polymers, such as gelatin, collagen, silk, fibrin, dextran, matrigel, 
hyaluronic acid, alginates, chitosan and agarose, have been used as biomaterials 
for a long time [1, 35, 44 - 48]. Since these natural polymers are components of 
extracellular matrix, they are biocompatible and suitable as biomaterials for 
engineered tissue. However, these natural polymers have some limitations. The 
first is limited mechanical properties and degradation rates that is not easy to 
control, secondly, these natural polymeric materials extracted from plant, animal 
or microbe that contain xenogeneic protein, microbes or/and viruses may provoke 
immune response [1, 35, 45, 47]. In despite of this, natural polymeric materials 
are still having promising prospects in tissue engineering application such as 
vehicles of drug delivery and blend with other materials to improve their physical 
and biological prosperities each other [1, 35, 44 - 48].  
 
2.3  3D Porous Scaffolds Fabrication Technology for Tissue 
Engineering 
A number of approaches to fabricate 3D porous scaffolds for tissue engineering 
applications have been explored such as scaffolds moulding, particle leaching, 
textile technologies, emulsification/freeze drying, liquid-liquid/liquid-solid phase 
separation, gas foaming, electrospinning, solid freeform fabrication, solvent 
casting, and lithographic [1, 32, 49, 50]. However, there are many disadvantages 
associated with these fabrication methods, for example, lack of interconnectivity, 
the use of toxic chemical solvent, poor mechanical strength and limited control of 
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pore size [1, 32, 49, 50]. These drawbacks can contribute to implant failure. In 
order to obtain optimal fabrication technology, there is a continual search for new 
technologies and improvement of existing methods. The techniques are utilized in 
fabricating 3D porous scaffolds can be categorized into four methods: 
(1) Textile; 
(2) Solvent casting with particulate leaching; 
(3) Gas Foaming/Phase Separation/ Freeze-drying; 
(4) Solid Freeform Fabrication; 
2.3.1 Textile 
 
Figure 2.3. Illustration of 3D porous scaffolds fabricated via electrospining 
apparatus, adapted from Ref [49] with modification. 
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Presently, textile technologies such as non-woven, knitting, electrospinning and 
fiber bonding routes have the potential of being used to manufacture 3D porous 
scaffolds [51 - 53]. This is because the textile manufacturing methods utilizes 
fibers which provide the largest surface area to volume ratio, thus, making it 
suitable as a matrix material for 3D porous scaffolds. Electrospinning is a 
fabrication process which uses an electric to control the polymer fibers fabrication 
has been reported to be capable of fabricating polymer fibres from nano-scale to 
micro-scale in size (Figure 2.3) [54 - 56]. This technology can be used to co-spin 
polymers with a variety of biomolecules, leading to the fabrication of functional 
fibres. For example, PGA and PLA fibres are combined with collagen in order to 
improve their biocompatibility [54 - 56]. Other textile technologies that are used 
are non-woven and knitting techniques. These two technologies that are 
commonly used to fabricate 3D scaffold are simpleness, convenience, and involve 
non-toxic chemicals solvent. Using non-woven combined of polymer fibers such 
as PGA, PDLA and PLLA has been used in tissue engineering bone, cartilage, 
heart valves, bladder, and liver [54 - 56]. However there are several limitations in 
textiles such as structural instability, poor mechanical properties to withstand 
biomechanical loading and difficulty in controlling pore size and pore shape [57, 
58].  
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2.3.2 Solvent Casting with Particle Leaching 
 
Solvent casting technology involves dissolving polymer using a suitable solvent 
and pouring into a mould to form thin polymer film. This process is a simple and 
convenient way to produce porous 3D scaffolds. However, only for thin 
membranes or very thin 3D porous scaffolds are fabricated using this technique 
[24, 36 - 43]. In order to overcome this problem, a modified method using 
laminated thin sheets to make thicker polymer film was introduced. The drawback 
of layering thin porous sheets is that it is time consuming, and produces limited 
interconnectivity. This technology is rarely used in the scaffolds fabrication 
excepting hybrid with particle leaching [1, 59 - 66].  
  
 
Figure 2.4. Schematic illustration of scaffolds fabricated by solvent casting and 
particle leaching. 
 
Solvent casting with particle leaching technology involves casting polymer 
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solution containing water soluble particulates such as salt, sugar, paraffin spherule 
and other leachable solid into a mould (Figure 2.4). After evaporation of the 
solvent, the particulates are leached away from the polymer mould using water to 
produce the pores of the 3D scaffolds. This is an uncomplicated method to 
fabricate 3D scaffolds. However, the extensive use of solvents (most of which are 
toxic) and residual solvent are one of the major shortcomings of this technology 
for fabricating 3D porous scaffolds [1, 59 - 66]. Although efforts are taken to 
remove the solvents, residual solvents may leached from the scaffolds and hinder 
cell attachment, proliferation and can even cause severe inflammatory response in 
vivo. Another disadvantage of this method is the lack of interconnectivity [1, 59 - 
66]. In this technology, pores and interconnectivity of scaffolds are usually 
achieved by adjacent particles coming into contact with each other. As the 
particles dissolve in water, pores fabricated by particles are frequently fused 
together, leading to pores collapsing and poor interconnectivity. 
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2.3.3 Gas Foaming/Phase Separation/ Freeze-drying 
 
        
Figure 2.5. Sketch map of scaffolds fabricated by gas foaming processing. 
 
Another popular technique used to fabricate 3D scaffolds is gas foaming. High 
pressure gas forming techniques uses inert gas, usually CO2 and N2, at 
supercritical condition (above critical temperature and critical pressure of gas) to 
fabricate 3D porous scaffolds [1, 47 - 73]. In this process, polymer solid samples 
or discs will be placed in the vessel exposed to supercritical gas with a variety of 
processing parameters such as ST, P, T and depressurization rate or VT. The first 
three parameters will enable critical gas to infiltrate and saturate into the polymer 
samples. Subsequently, rapid or slow depressurization to ambient pressure lead to 
CO2 and N2 nucleation, forming pores in the polymer (Figure 2.5) [47 - 73]. The 
 21
gas-foaming process is favourable for incorporating biological molecules and 
cells into scaffolds because it avoids using toxic solvents in scaffolds fabrication 
[1, 47 - 73]. However, the resultant porous scaffolds contain a mixture of open 
and closed pore structure and a non-porous surface. This limitation can be 
addressed by combining it with particle leaching technique [1].  
 
       
Figure 2.6. Schematic illustration of 3D porous scaffolds fabricated with phase 
separation processing, adapted from Ref [1] with modification. 
 
TIPS technology has been used to fabricate drug delivery to fabricate 
micro-sphere to incorporate medicine [1]. Recently, TIPS become a popular 
technology to fabricate 3D porous scaffolds [1, 74 - 78]. In this processing, a 
change in temperature can cause the solvent to be thermodynamically unstable 
and this will induce a phase separation of the polymer blend, that is, polymer rich 
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phase (high polymer concentration) and polymer lean phase (low polymer 
concentration). The solvent in the polymer lean phase is then removed via 
extraction, evaporation and lyophilisation, producing a porous network (Figure 
2.6) [1]. The polymer rich phase is solidified, producing the structure of the 
scaffold. The micro-architecture of the 3D porous scaffolds can be controlled by 
change phase separation conditions such as type of polymer, solvent, polymer 
concentration and temperature [1, 74 - 78]. Since this technique uses organic 
solvents to fabricate pores within the scaffolds, removal of solvent is still a critical 
problem as this potentially can be a source of toxicity for cells [1].  
 
        
 
Figure 2.7. Schematic illustration of scaffolds fabricated with freeze-drying 
processing, adapted from Ref [49] with modification. 
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Emulsion and freeze-drying is a method for rapid fabrication of 3D scaffolds with 
controllable porosity and average pore diameter [1]. An organic solution 
containing dissolved polymer is combined with a suitable amount of water and 
emulsified until homogeneity is achieved [1, 74 - 78]. The resulting emulsion is 
poured into a metal mould of specified dimensions and is frozen with liquid 
nitrogen. Freeze-drying step removes the water and solvent to yield 3D porous 
scaffolds of highly interconnected pores (Figure 2.7). Porosities of up to 90% and 
median pore diameters from 15 to 35 μm can be achieved [1, 74 - 78]. This 
technique has been utilized with many biocompatible polymers, including 
chitosan, PGA, PLLA, PLGA, and PPF blends, however, the reduction or removal 
of residual solvent still remains a challenge. 
 
Non-emulsion-based freeze-drying is also capable of producing porous polymeric 
scaffolds. Synthetic polymers are dissolved in glacial organic solvents are frozen, 
and then the solvent is removed by freeze-drying [1, 74 - 78]. Sublimed ice 
crystals generate pores, with pore size being controlled by solution parameters 
such as freezing rate, temperature, ionic concentrations, and pH value. 
 
2.3.4 Solid Freeform Fabrication  
 
The microstructure of 3D porous scaffolds such as interconnectivity, pore size and 
shape are one of the most important parameters of scaffolds fabrication and 
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application such as mechanical properties, controlled release characteristics, cell 
proliferation, vascularisation and tissue formation onto porous 3D scaffolds. 3D 
porous scaffolds fabricated via current methods including solvent casting, 
freeze-drying, phase separation and gas forming lack of precise control of internal 
architecture and interconnectivity. How to precise control microstructure of 3D 
porous scaffold during fabrication become a critical issue and need to be 
addressed. For these reasons, a new 3D porous scaffolds fabrication technique 
known as SFF is fabricated. SFF can fabricate 3D porous scaffolds with high 
degree control microstructure. Currently, there are more than 20 SFF technologies 
but only a few of them have been used to fabricate 3D porous scaffolds [1, 79 - 
81].  
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2.3.4.1 Three-dimensional Printing  
 
       
Figure 2.8. Sketch map of 3D porous scaffolds fabricated with three-dimensional 
printing, adapted from Ref [1] with modification. 
 
3DP was developed at Massachusetts Institute of Technology [1]. The setup of a 
3D printer consists of a building platform, powder dispending roller and a print 
head. This process produces object by ink-jet printing a binder onto powder layers. 
Polymeric and ceramic powders that are used as scaffold materials are spread over 
the surface of the building platform. A binder, acting as the solvent which has 
been specifically selected for the polymer is ejected onto the powder. The layer of 
powder in contact with the binder is partially dissolved, enabling the powder to 
fuse. After one layer is built, the platform then lowers so that the second layer of 
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powder can be spread and selectively bonded (Figure 2.8) [1]. This process need 
repeat until the entire object is completed. However, the loose powder trapped in 
the channels and need to be removed during the post-processing step. Using 
chemical solvent as binder excludes the incorporation growth factors, protein and 
cells in 3DP technology [1, 82 - 86].  
 
2.3.4.2 Fuse Deposition Modeling  
 
 
 
Figure 2.9. Schematic illustration of 3D porous scaffolds fabricated with fuse 
deposition modeling, adapted from Ref [89] with modification. 
 
The FDM uses thermoplastic polymeric filaments to manufacture scaffolds. The 
thermoplastic filaments are heated to a semi-liquid state, extruded and laid down 
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as strings with defined pattern on the platform (Figure 2.9) [1, 89]. The scaffold is 
built layer by layer. Unlike 3DP and SLS, solvent is not used in this processing 
and no loose unbound powder trapped in the scaffolds. However, FDM requires 
high temperature to melt thermoplastic materials [1, 87 - 89]. This will restrict 
incorporation of cells, protein and growth factors on the scaffolds in the 
processing. 
 
2.3.4.3 Ink-jet Printing and Indirect Casting  
 
       
Figure 2.10. Schematic illustration of 3D porous scaffolds fabricated with ink-jet 
printing and indirect casting, adapted from Ref [49] with modification. 
 
Ink-jet printing system consists of a build platform and two print jets (Figure 2.10). 
 28
Two print materials which are building materials and support materials are used. 
The build jet prints droplets on build platform, then support jet prints support 
material around the printed build materials. After that the cutter cuts the build 
layer to a predetermined thickness. The scaffold is built via repeated process until 
the whole object is completed [1, 90 - 94]. In this technology, using heat treatment 
for build materials will restrict incorporation of cells and growth factors on the 
scaffolds in the processing [1]. Based on this technology, bio-printing that could 
be used to fabricate substrates that replace organs or even entire organisms from 
raw biological materials has been introduced. 
 
2.3.4.4 Stereolithography  
 
         
Figure 2.11. Schematic illustration of 3D porous scaffolds fabricated via 
stereolithography, adapted from Ref [49] with modification. 
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The principle of SL is based on the photopolymerization of photopolymer resins. 
The materials for SL are sensitive to UV and can be cured at UV. The 
photopolymerization process is activated by a computer controlled UV laser raster 
on the resin surface which cures the liquid resin into the shape on the first layer. 
The elevator will move down to a distance and allow the uncured fresh resin to 
cover the first layer. The computer will control the UV laser on the fresh resin 
surface and build the second layer [95 - 98]. This process will repeat and until 
whole part is made (Figure 2.11). When completed, the scaffold will be removed 
from the platform and rinsed in solvent to get rid of uncured resin. Using UV and 
solvent to clean uncured resin limit incorporation of cells and growth factors on 
the scaffolds in the processing and cause cytotoxicity in application.  
 
2.3.4.5 Selective Laser Sintering  
 
Figure 2.12. Schematic illustration of 3D porous scaffolds fabricated via selective 
laser sintering, adapted from Ref [99] with modification. 
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This technology uses CO2 laser to roast the polymeric powder in the container to 
the melting point and this will cause the polymer powder particles to fuse, 
forming a solid mass (Figure 2.12). After the layer is built, a fresh coating of 
powder will be placed on the newly fabricated layer. The laser, controlled by a 
computer will gradually build the scaffold layer by layer [100 - 102]. There are, 
however, a few disadvantages associated with the SLS. On the one hand, there are 
high temperature used in processing and small unsintered particles trapped inside 
of scaffolds and need to be removed from channels during post-processing step; 
on the other hand, partial fused powder can make the cleaning step difficult; the 
thirdly, the trapped loose powder would cause cytotoxicity in vitro study [100 - 
102]. 
 
2.4  Cell Source for Tissue Engineering 
 
An ideal cell source for tissue engineering should satisfy with the following 
conditions: easy to obtain and able to proliferate in vitro [103]. So the cell sources 
of tissue engineering use primary cells are autologous cells that can be taken from 
the patient and autologous cells can reduce host immune response. However, the 
quality of the cells isolated may not be ideal due to patients suffering from tissue 
damage or organ dysfunction [103]. Therefore, in the last two decades, stem cells 
have drawn more attention as a new promising cell source for tissue engineering 
[1, 104 - 109]. There are two type of stem cells used, ES cells and adult stem 
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cells.  
 
 
 
Figure 2.13. Adult and embryonic stem cells of medicine application, adapted 
from Ref [110] with modification. 
 
ES cells are isolated from early human blastocyst and have the ability to 
differentiate into different types of cells in the human body [104 - 109]. This is 
known as pluripotency (Figure 2.13). However, ethical issue and in vitro 
differentiation restrict the use of embryonic stem cells in regenerative medicine. 
 
Adult stem cells, also referred to as postnatal stem cells, have been isolated from 
many tissues in the human body and provoke less ethical issue. Adult stem cells, 
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like ES cells, reside in many tissues throughout the whole body and retain their 
ability to differentiate into multiple tissue types (Figure 2.13) [104 - 109]. Bone 
marrow derived stem cells such as HSCs, MSCs and ADCs have been shown to 
differentiate into hematopoietic lineages such as red blood cells and connective 
tissue lineages for example, bone, cartilage, skeletal muscle and myocardial cells 
[104 - 109]. 
 
Despite the literature demonstrating ES and adult stem cells been successfully 
used in biomedical experiments and even clinical experiments such as 
transplanting autologous adult stem cells for the treatment of heart disease, brain 
disease, neuron injury and diabetes, there are some interesting questions which 
remain unanswered [104 - 109]. They are: (1) what is the best origin of adult stem 
cells? (2) what are the optimal isolation and expansion techniques to obtain 
therapeutic quantities of stem cells? (3) what population of stem cells is most 
potent? (4) can stem cells move from one tissue to another tissue after transplant 
into damaged tissue to lead to unnecessary regenerative cells?  
 
2.5  Tissue Engineering Porous 3D Scaffolds Applications 
 
3D Porous scaffolds play an important role in tissue engineering or regeneration 
medicine. Scaffolds act as a temporary substitute which mimic natural 
environment for cell accommodation, proliferation and differentiated then for 
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neo-tissue formation. The aim of this part is general description 3D porous 
scaffolds in tissue engineering application such as cardiovascular system, bone 
and cartilage, nerve system, skin and controlled release.  
 
2.5.1 Cardiovascular System  
 
CAD such as MI and HF and so on are one of the major health problems and one 
of the highest leading causes of death in the world. The myocardium is a 
terminally differentiated tissue. This means that they are not able to regenerate 
and cannot compensate by themselves during MI and HF. During the last-phase of 
heart failure, mechanical VADs or heart transplantation are the only clinical 
options [111 - 123]. However, due to high expense and lack of donor’s organ, 
many patients died while waiting on the hospital shortlist. CTE can assist in 
overcoming these issues by providing a potential alternative [111 - 123]. 
 
The purpose of CTE is to repair or regenerate a damaged section of the heart. 
Cardiac tissue engineering include design and fabrication path or 3D porous 
scaffolds fabricated from synthesis biodegradable polymeric materials combined 
with stem cells and/or growth factors which can be delivered to damaged heart 
tissue and stimulate regenerative heart tissue to replace scarred heart tissue 
(Figure 2.14) [111 - 123]. The ideal 3D porous scaffolds for myocardial 
regeneration should satisfy these conditions: ⑴ the materials and degradation 
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products must be nontoxic and non-immunogenic, ⑵ optimal porosity and pore 
size guide cell proliferation, differentiation and organization, ⑶  support 
development of functional vasculature and ⑷ excellent elastomeric mechanical 
properties that suit for heart pulsation. The function of these scaffolds is delivery 
cells and/or growth factors to the damaged area on the heart; and the cells 
integrate with host tissue to form new capillary vessels to supply oxygen and 
blood to damaged heart [111 - 123].  
 
 
 
Figure 2.14. Strategies of treatment of myocardial infarction use cells and tissue 
engineering scaffolds. 
 
Cardiac tissue engineering can deliver cells and gene to damaged heart tissue from 
scaffolds and reduce symptom and improve heart function in the lab experiment 
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but there are many issues that need to be addressed before clinic trial [111 - 123]. 
At present most important drawbacks of cardiac tissue engineering include: (1) 
using optimal biomaterials to fabricate 3D porous scaffolds with desirable 
biocompatibility, biodegradability, microstructure and mechanical properties; (2) 
to identify the best cell source, ideal population and optimal time for cell 
transplantation; (3) to explain electrophysiology activity of cell implanted; (4) to 
find the long-term survival rate after cell implanted; (5) to detect the long-term 
and systemic effect of gene delivery; (6) to look for optimal delivery methods for 
cells and gene to the heart [111 - 123].  
 
2.5.2 Bone and Cartilage  
 
The human body can to some extent, repair fracture or small defects. Large 
defects, however, as a result of congenital abnormalities, trauma and disease 
cannot be repaired by the body without assistance [124 - 135]. These large defects 
are traditionally treated via autologous bone and/or acellular cadaver bone 
transplant. These can cause serious problems such as disease transmission, 
immune reaction from xenograft and large area donor site for autologous become 
another injury site of patients [124 - 135]. To address these limitations with bone 
regeneration, tissue engineering scaffolds hold great foreground. In this program, 
biodegradable porous 3D scaffolds with optimal porosity and pore size are 
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constructed seeded with functional cells and growth factors implantation to the 
desired place (Figure 2.15) [124 - 135].  
 
Figure 2.15. Autologous chondrocyte transplantation strategies of treatment of 
cartilage damage use cells and tissue engineering 3D scaffolds, adapted from Ref 
[132] with modification. 
 
Cartilage tissue engineering provides alternative possible therapeutic method to 
restore lost tissue and organ function. Many scientists have focused on bone and 
cartilage tissue engineering with exciting results that will continue to impulse 
much research efforts to engineered cartilage tissue. However, in bone and 
cartilage tissue engineering cell source, scaffolds, and materials are still three 
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important effect factors [124 - 135]. Further development of bone and cartilage 
tissue engineering need focus to (1) develop novel biomaterials with excellent 
biocompatibility; (2) fabricate 3D porous scaffolds with optimal mechanical 
properties and microstructure that match the local tissue; (3) use suitable cell 
source for bone and cartilage tissue engineering.  
 
2.5.3 Nerve System 
 
CNS and PNS are two major divisions in the nerve system in organism. Accident 
and disease such as stroke, spinal cord injury, peripheral injury and Parkinson’s 
disease can lead to nerve damage [1, 136 - 146]. Current therapy methods for 
nerve injury are xenograft and autograft. These also can lead the some problems 
such as immune reaction, disease transmission and cause another part of body 
local nerve loss [1, 136 - 146]. To date, nerve regeneration use hollow tube 
contained with cells and NGF and sustained release from tube. Cells and growth 
factors may keep high concentration at local tissue and stimulate nerve cells repair 
[1, 136 - 146]. However, nerve regeneration with tube has been only partially 
successful in the PNS [1]. 
 
3D scaffolds have been used in peripheral nerve system regeneration including gel, 
fibers, and sutures. 3D porous scaffolds and microspheres are combined with cells 
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and growth factors to promote nerve growth (Figure 2.16) [1]. However, the 
limitations of these approached is finite ingrowth of nerve cells (Schwann cells) 
into the distal end. Schwann cells are one of most important cells in nerve system 
and play an important role to support axonal regeneration after damaged. These 
cells secrete regulatory proteins that aid in neuronal survival and axonal growth. 
Limited ingrowth of Schwann cells lead to lack of cell connection in the damaged 
nerve [1]. Once the Schwann cell migration is improved, nerve regeneration will 
be promoted [1, 136 - 146]. 
 
 
 
 
Figure 2.16. Strategies of treatment of nerve system damage use cells and 3D 
tissue engineering scaffolds, adapted from Ref [1] with modification. 
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The uses of 3D porous scaffolds in repairing peripheral nerve system have been 
successful [1]. However, this did not translate to the central nervous system which 
demonstrated limited success. This was due to complex structure and 
physiological function of central nervous system [1]. Currently, 3D porous 
scaffolds are the primary step in the development of central nerve system therapy.  
 
2.5.4 Skin  
 
Every year, several thousands of people require skin graft due to dermal damage 
from sources such as chemicals, heat, electricity, nuclear energy and UV injury 
[147 - 159]. Most skin damage is limited to the epithelium and do not need skin 
graft. More serious traumas can lead to dermal and sub-dermal tissue partial or 
complete damage. Unfortunately, dermal and sub-dermal tissue can not heal by 
themselves. Although patients who suffer from skin damage up to 90% of their 
body can survive, these patients experience loss of skin function and lower living 
quality [147 - 159]. Currently, treatment for damaged skin involves grafting of 
cadaver skin, xenograft and autograft. These approaches are trouble with disease 
transmission, immune reaction of xenograft and lacking enough healthy skin and 
donor site for graft become another injury site of autograft [147 - 159]. 
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Figure 2.17. Strategies of treatment of skin damage use cells and 3D tissue 
engineering scaffolds, adapted from Ref [158] with modification. 
Tissue engineering of skin requires the ideal materials to be permeable to oxygen 
and porosity that mimics skin to enable nutrient supply, waste and liquid diffusion. 
The material should provide mechanical support similar to native skin, and be 
conducive to cell proliferation and integration with the surrounding tissue (Figure 
2.17). Finally, the graft should consist of 3 layers, dermal, epidermal and 
subcutaneous tissue which prevents bacterial infection and recovery partial skin 
function such as perspiration and sense [147 - 158]. Current research focuses on 
how to regenerate dermal and/or epidermal layer by seeding cells including sweat 
gland cells onto graft materials to recover skin function. While skin is one of the 
most successfully tissue engineered organ, recreating functions such as 
perspiration and sensation still remains a challenge. [147 - 158]. 
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2.5.5 Controlled Release 
 
Figure 2.18. Illustration of controlled release from 3D porous scaffolds, adapted 
from Ref [1] with modification. 
3D porous scaffolds serve a critical role in tissue engineering and regenerative 
medicine [1]. The scaffold fabricate a space that can mimic the natural 
environment for tissue formation by providing a substrate for cell attachment that 
presents chemical, biological, and/or mechanical cues. Additionally, scaffolds 
have also been used as controlled release vehicles that can maintain therapeutic 
concentrations of diffusible growth factors, protein and medicine in the local 
tissue [160 - 169].  
Controlled release gene, protein or growth factors from tissue engineering 
scaffolds to host tissue have become a significant method to encourage cell 
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proliferation, differentiation and formation of regeneration tissue (Figure 2.18). 
Controlled release includes incorporate medicine, gene and growth factors into 
scaffolds and they are released via diffusion-controlled mechanism or released via 
the scaffolds degradation to local tissue that 3D scaffolds have been placed and 
stimulate local regeneration tissue formation [160 - 169]. However, there are 
some interesting questions need further investigate. The first, the best method of 
incorporate medicine, gene and growth factors into scaffolds; the secondly, 
controlled release profile of medicine, gene and growth factors from scaffolds; the 
thirdly, protection the bioactivity of medicine, gene and growth factors 
incorporated into scaffolds [160 - 169].  
 
2.6  Current Issues for 3D Porous Scaffolds in Tissue 
Engineering and Challenge 
 
Although 3D porous scaffolds provide promising prospects in regeneration 
medicine and have got a lot of excited research results. 3D porous scaffolds still 
have lots of issues need answer before they go to clinic on a large scale [1, 7, 32]. 
The first is materials biocompatibility. Biocompatibility of materials includes 
cytotoxicity, immunity, inflammation response, and mutagenesis/carcinogenesis 
in vitro and in vivo testing of raw materials, remnant chemical solvent, and 
degradation product of materials. The secondly is materials bio-functionality. 
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Bio-functionality means that if materials bio-safety can be excluded host cells or 
stem cells are able to attach, spread, proliferate and differentiate on materials 
surface or scaffolds. These cell functions are affected by chemical group of 
surface of materials, hydrophilicity, and morphology of surface, microstructure of 
scaffolds such as pore size, porosity and interconnectivity of scaffolds. The thirdly 
is mechanical properties of materials and scaffolds must suit for host tissue. 
Different mechanical properties of materials and scaffolds depend on molecular 
weigh, chemical structure of materials and microstructure of scaffolds. The last is 
biodegradability of materials or scaffolds. Soft tissue replacement need substitute 
degradation and replacement by host regeneration tissue and the degradation 
product can be disposed by metabolism of host without any toxicity [170 - 179].  
 
2.7  Summary 
 
Over the past decades, there has been a great interest in tissue engineering and this 
has resulted in numerous publications for material synthesis and modification, 
scaffolds fabrication and their application in tissue engineering. This chapter 
reviews three vital factors of tissue engineering, current issue of tissue 
engineering and tissue engineering application. The three critical factors 
mentioned above are still attractive research field in tissue engineering and require 
further investigation. 
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CHAPTER THREE 
 
3 Fabrication and Characterisation of 
Thermoplastic Polyurethane/Polystyrene Blend 
3D Scaffolds via Supercritical Carbon Dioxide 
 
3.1 Introduction 
 
3D porous polymeric scaffolds have attracted increased attention in regenerative 
medicine. An ideal scaffold should be biocompatible, 3D and contains well defined 
microstructure with a network of interconnected pores. The mechanical properties 
need to be similar to the native tissue that it is mimicking. Bioactive factors can be 
added to enhance and guide the tissue regeneration process in a controlled manner 
[1]. Number of approaches to make 3D porous scaffolds for TE applications such 
as scaffolds moulding, particle leaching, textile technologies, emulsification/freeze 
drying, liquid-liquid phase separation, gas foaming, electrospinning, solid freeform 
fabrication, solvent casting, and lithographic have been introduced in the literature 
[1]. However, there are many disadvantages in these fabrication methods, for 
example, lack of interconnectivity, the use of chemical solvents, poor mechanical 
strength and limited control of pore size [1]. These drawbacks can contribute to 
scaffolds implant and/or transplant failure. There is still a continual search for new 
technologies and improvement of existing methods to obtain optimal fabrication 
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methods [1].  
 
scCO2 is an inexpensive, non-toxic, non-flammable gas that is available in high 
purity from a variety of sources. Above the critical temperature and pressure (Tc = 
31.1 oC, Pc = 73.8 bar), scCO2 demonstrates the unique properties of combined 
gas-like diffusivity and liquid-like density. These unique properties of scCO2 can 
be used as a processing medium for the production either of fine particles or to 
function as a porogen in the production of porous foams [1, 2 - 17]. Recently, a 
number of studies have reported using various types of polymer such as 
poly(DL-lactic acid), poly(lactic-co-glycolic acid), poly(caprolactone), polystyrene, 
poly(methyl methacrylate), poly(ethylene terepthalate), and polymer blend of 
poly(ethyl methacrylate) and tetrahydrofurfuryl methacrylate to fabricated 3D 
scaffolds via scCO2 [1, 2 - 17].  
 
TPU is a linear segmented multi-block copolymer containing a [HS] n type 
structure, whereby H and S represent hard and soft segments respectively. The 
hard segments are typically composed of diisocyanates and a low-molecular 
weight diol and/or diamine. The soft segments contain flexible polyether or 
polyester glycols. Morphology and physicochemical properties of TPU are 
controlled by different types of soft and hard segments and their composition 
ratios [180 - 182]. TPU family have been widely used to industry and engineering 
tissue such as engineering material, coatings, adhesives, cardiovascular biomaterial, 
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haemodialysis blood line sets, CVC, long term implantation catheters in human 
body and IV bags [18, 19, 183 - 185]. This is largely due to the excellent 
physicochemical properties and biocompatibility [18, 19, 183 - 185]. TPU 
scaffolds fabricated via solvent casting/particle leaching, electrospin, inkjet, salt 
leaching/freeze-drying and TIPS have been used to engineering tissues such as 
artificial skin, cardiovascular implants, nerve conduits, cancellous bone graft 
substitutes, and articular cartilage [20 - 26]. However, little work has been focused 
on TPU scaffolds fabricated via scCO2 combined with solvent etching to improve 
interconnectivity for TE application. 
 
PS is a versatile thermoplastic polymer. It has been used in a wide application in 
industry fields with a lot of excellent properties, such as high electrical resistance, 
good mechanical properties and high workability, thermal stability under various 
processing conditions [186 - 193].  As biomaterials polystyrene has been widely 
used as 2D cell culture substrates (TCPS) in vitro. Recently, some methods have 
been applied to produce 3D structures on polystyrene surface, such as, 
microgrooves with the width/spacing/depth of 10/20/3 mm were fabricated by 
casting; nano-grooves with a periodicity of 500 nm and different depths of 50 nm 
and 150 nm were fabricated by Langmuire Blodgett lithography; and nanofibres 
with the mean diameter from 1 mm to 0.66 mm were prodded by electrospinning, 
to study cell attachment, spreading and proliferation properties [186 - 193]. 
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Because TPU and PS are all biomaterials and they have immiscible and phase 
separation physical properties in their blend, in this chapter, TPU and PS blend 
(TPU/PS wt% 90/10) porous scaffolds were fabricated using scCO2 with different 
processing conditions such as VT, T, P and ST. The microstructure and physical 
properties of 3D TPU/PS blends porous scaffolds were assessed.   
 
3.2 Materials and Methods 
 
3.2.1 Materials 
 
Thermoplastic polyurethane (Irogran, PS455 - 203, contains ~ 10% aromatic 
diisocyanate (hard segment), ~ 32 % aliphatic and cycloaliphatic dicarboxylic acid 
and ~ 58 % aliphatic diols (soft segments); Mw = 40,000, Density: 1.19 g/cm3; Tg: - 
45 oC, Tm: 33.4 oC (DSC data); kindly donated by Huntserman TPU, USA) [194, 
195]. Polystyrene (Mn = 190,000, Sigma-Aldrich, USA). Carbon dioxide 
(Compressed carbon dioxide, Coregas PTY, LTP, Australia). All of the chemicals 
and solvents were purchased from Sigma Aldrich, unless otherwise noted. 
Chemical structure formula of TPU and PS are shown in scheme 3.1.  
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Hard segment: 
 
CH2 N C ONCO
O H H O
 
 
Soft segment: 
 
        
O C CH2 CH2 CH2 CH2 C O
O O
O CH2 CH2 CH2 CH2 O  
 
Thermoplastic polyurethane, Mn = 40,000  
 
CH2 CH
n
 
 
Polystyrene, Mn = 190,000 
 
Scheme 3.1. Chemical structure formula of thermoplastic polyurethane and 
polystyrene. 
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3.2.2 Fabrication of 3D TPU/PS Blend Porous Scaffolds 
  
The polymer blend solution of TPU/PS (wt%) 90/10, was prepared by dissolving 
TPU and PS in THF. This blend was stirred for 24 hours at room temperature to 
form homogeneous state and poured into Teflon module. All samples were placed 
in fume hood overnight for the solvent to evaporate and further dried in the 
vacuum to remove the residual solvent. TPU/PS (wt%) 90/10 blend discs of 0.8 cm 
in diameter and 2 mm thick were cut via hole punch. 
 
Discs of TPU/PS blend were placed into a 100-ml supercritical fluid extraction 
vessel (Applied separation, USA). The instrument is equipped with pressure 
monitor, temperature and venting controller. The vessel was immediately filled 
with CO2 and heated to a desired T of 35 oC, 45 oC and 55 oC; and then pressurized 
to certain P range form 100 bar, 200 bar and 300 bar; over a desired ST of 60 
minutes, 120 minutes and 180 minutes. After that the vessel was depressurized to 
ambient pressure with a preset VT of 5 seconds, 30 minutes and 60 minutes via 
venting controller.  
 
3.2.3 Structural Analysis and Porosity Evaluation 
 
SEM was used to determine the microstructure of the 3D TPU/PS blend (wt% 
90/10) porous scaffolds. The 3D TPU/PS blend porous scaffolds were freeze 
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fractured in liquid nitrogen and cross-sections were mounted on aluminum stubs to 
be coated with gold in a sputter coater at 40 mA for 120 seconds. (Quorum 
Technologies, UK). The scaffolds were then observed using SEM (Leica, S440, 
Germany) with an acceleration voltage of 5 KV. The distribution of pore size was 
obtained by digital imaging analysis system. At least 30 pores were calculated 
from three different areas of the same samples.  
 
Scaffold porosity (ε) was measured from the mass and the volume of scaffolds 
samples according to the following formula 3.1: 
 
ε = 1- (ρs / ρm)                              (3.1) 
 
where ρs is the apparent density calculated from the mass and the volume of the 
cylindrical scaffolds and ρm is the density of TPU (1.19g/cm3).  
 
3.2.4 Mechanical Properties Assessment 
 
Mechanical properties were obtained through compression testing using an Instron 
tensile tester (Model: 2663-821 Advanced Video Extensomerter 30 KN Instron, 
USA). The cylindrical scaffolds with 0.8 cm in diameter and 4 mm thick were 
tested at a cross head speed of 1mm/s. A full scale load of 3KN was used for the 
3D TPU/PS blend porous scaffolds. Compression modulus (E) was calculated as 
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following equations 3.2, 3.3 and 3.4: 
 
Stress = σ = F/A                             (3.2) 
Strain = ε = ΔL/L                            (3.3) 
E = σ / ε                                   (3.4) 
 
Where F is the loading force, A is the cross sectional area, ΔL is the change in 
length and L is the original length.  
 
3.3  Results 
 
3.3.1 Physical Properties and Morphology of 3D TPU/PS 
Blend Porous Scaffolds Fabricated via scCO2 with 
Different Processing Parameters 
 
TPU/PS blend porous scaffolds were fabricated using scCO2 with different 
processing parameters. Their physical properties are summarised in Table 3.1. All 
date were presented as means ± standard error of means. SEM images showed 
that TPU and PS were immiscible (Figure 3.1). Two phases, TPU rich phase and 
PS lean phase can be seen in the 3D TPU/PS blend porous scaffolds. The round 
particles observed in Figures 3.1, 3.3, 3.5 and 3.7 are PS particles which were 
separated from the TPU during processing. 
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Table 3.1. Physical properties of 3D TPU/PS blend porous scaffolds fabricated via 
scCO2 
 
 
 
 
 
 
 
 
3.3.1.1 Effect of Depressurization Rate 
 
It can be seen from Table 3.1, Figures 3.1 and 3.2, that venting time affected the 
microstructure of the scaffolds. When the vessel was depressurized for 5 seconds, 
non-uniform structures were produced (Figure 3.1 A). The average pore size and 
porosity of scaffolds produced with 5 seconds of venting was 40.5 ± 16.8 µm, and 
81 ± 7.23% respectively. The density of this scaffold was 0.23 ± 0.03 g/cm3 and 
the compression modulus was 107 ± 13 MPa (Figure 3.2). As the venting time 
increased to 30 and 60 minutes the pore size of the scaffolds increased while the 
porosity decreased (Figure 3.1 B and Figure 3.1 C). The average pore size is larger 
at 104.3 ± 38.2 µm when produced at 30 minutes venting time. The porosity was 
75.6 ± 4.1 %. The density and compression modulus of the scaffolds fabricated at 
Variable    Pore size 
(µm)   
Porosity 
(%)   
Density 
(g/cm3) 
Modulus 
(MPa) 
VT:  5 sec   
30 min   
60 min   
40.5± 16.8 
104.3±38.2
259±81.6 
81±7.23 
75.6±4.1 
43.6±2.1 
0.23±0.03 
0.29±0.08 
0.67±0.07 
107±13 
85±10 
43±7 
T:  45 oC  
55 oC    
129.1±58.7 
 
56.2±4.6 
 
0.52±0.07 
1.01±0.06 
128.5±21 
140±22 
ST: 120 min   
180 min   
70.1±20.2  
90.6±27.8 
70.7±6.3 
66±3.6 
0.35±0.07 
0.52±0.02 
90.2±23 
60.6±11 
P: 200 bar    
300 bar    
96.9±37.2 
215.7±58.5 
80.4±3.1 
75±4.2 
0.21±0.04 
0.24±0.03 
82.3±7.4 
55.3±6.7 
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30 minutes venting time was 0.29 ± 0.08 g/cm3 and 85 ± 10 MPa respectively 
(Figure 3.2). The venting time of 60 minutes produced scaffolds with the highest 
average pore size of 259.0 ± 81.6 µm and the lowest porosity of 43.6 ± 2.1 % in 
this experiment group. The density of scaffolds produced by a 60 minutes venting 
time was the highest at 0.67 ± 0.07 g/cm3 and had the lowest compression modulus 
of 43 ± 7 MPa across the 3 experimental groups (Figure 3.2).  
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Figure 3.1. SEM images of 3D TPU/PS blend porous scaffolds fabricated at 
different venting time, A: VT = 5 seconds, B: VT = 30 minutes, C: VT = 60 
minutes, T = 35 oC, P = 100 bar, ST = 60 minutes. Scale bar = 100 µm. 
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Figure 3.2. Physical properties of 3D TPU/PS blend porous scaffolds fabricated at  
different venting time, (A): Pore size, (B): Porosity, (C): Density and (D): 
Modulus.  
 
3.3.1.2 Effect of Temperature 
 
The effect of temperature was studied using two temperatures, 45 oC and 55 oC, 
while keeping the other parameters constant. It can be seen from Table 3.1, Figures 
3.3 A and 3.4, scaffolds fabricated at 45 oC had non-uniform pores with average 
pore size of 129.1 ± 58.7 µm. The porosity and density of the scaffolds was 56.2 ± 
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4.6 % and 0.52 ± 0.07 g/cm3 respectively. Scaffolds fabricated at 45 oC presented 
with a modulus of 128.5 ± 21 MPa. However, as the temperature increased to 55 
oC, there were significantly fewer pores on the scaffolds, and it was denser (1.01 ± 
0.058 g/cm3) than those manufactured at 45 oC. This density is similar to those of 
TPU (1.19 g/cm3). The modulus of scaffolds fabricated at 55oC was 140 ± 22 MPa 
(Table 3.1, Figure 3.4 D).  
 
 
 
 
Figure 3.3. SEM images of 3D TPU/PS blend porous scaffolds fabricated at 
different temperature, A: T = 45 oC, B: T = 55 oC. P = 100 bar, ST = 60 minutes, 
VT = 60 minutes. Scale bar = 100 µm. 
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Figure 3.4. Physical properties of 3D TPU/PS blend porous scaffolds fabricated at 
different temperatures, (A): Pore size, (B): Porosity, (C): Density, (D): Modulus. 
 
3.3.1.3 Effect of Soaking Time 
 
In order to study the effect of soaking time on scaffolds fabrication, the scaffolds 
were fabricated under different soaking time, from 120 to 180 minutes. Other 
processing conditions are T = 35 oC, P = 100 bar, VT = 60 minutes. As shown in 
Table 3.1, Figures 3.5 A and B, and Figure 3.6, the pore size of the scaffolds 
increased from 70.1 ± 20.2 µm to 90.6 ± 27.8 µm with the increase in soaking time. 
The porosity of these scaffolds, on the other hands, decreased from 70.7 ± 6.3 % to 
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66 ± 3.6 %. The density of these scaffolds produced at 120 and 180 minutes were 
shown to be 0.35 ± 0.07 g/cm3 and 0.52 ± 0.02 g/cm3 respectively. A reduction in 
the modulus of these scaffolds was observed with the increase in time, 90.2 ± 23 
MPa for 120 minutes and 60.6 ± 11 MPa for 180 minutes.  
 
 
 
 
 
Figure 3.5. SEM images of 3D TPU/PS blend porous scaffolds fabricated at 
different soaking time, A: ST = 120 minutes, B: ST = 180 minutes, P = 100 bar, T 
= 35 oC, VT = 60 minutes. Scale bar = 100 µm. 
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Figure 3.6. Physical properties of 3D TPU/PS blend porous scaffolds fabricated 
using different soaking times, (A): Pore size, (B): Porosity, (C): Density, (D): 
Modulus. 
 
3.3.1.4 Effect of Pressure 
 
The effect of pressure on the TPU/PS blend scaffolds was examined at 200 bar and 
300 bar with the remaining parameters being constant (T = 35 oC, ST = 60 minutes, 
VT = 60 minutes). Table 3.1, Figures 3.7 A and B and Figure 3.8 showed that the 
pore size of the scaffolds increased from 96.9 ± 37.2 µm to 215.7 ± 58.5 µm and 
porosity of these two samples decreased from 80.4 ± 3.1 % to 75 ± 4.2 % with the 
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pressure changing from 200 to 300 bar. In addition, the density of these scaffolds 
increased from 0.21 ± 0.04 g/cm3 to 0.24 ± 0.03 g/cm3, and the modulus decreased 
from 82.3 ± 7.4 MPa to 55.3 ± 6.7 MPa.  
 
 
 
 
 
Figure 3.7. SEM images of 3D TPU/PS blend porous scaffolds fabricated at 
different pressures, A: P = 200 bar, B: P = 300 bar, T = 35 oC, ST = 60 minutes, VT 
= 60 minutes. Scale bar = 100 µm. 
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Figure 3.8. The effect of pressure on the physical properties of 3D TPU/PS blend 
porous scaffolds, (A): Pore size, (B): Porosity, (C): Density, (D): Modulus. 
 
3.3.2 Mechanical Properties 
 
Figure 3.9 showed that compression stress-strain behavior of all 3D TPU/PS blend 
porous scaffolds fabricated via different parameters. The compression stress-strain 
profile showed that all 3D TPU/PS blend porous scaffolds had no obvious yield 
point and possessed well-defined compressive mechanical properties and excellent 
elastic properties except 3D TPU/PS blend porous scaffolds fabricated at 55 oC 
and 2D TPU/PS disc. TPU/PS scaffolds fabricated at 55 oC showed similar 
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stress-strain profile with 2D TPU/PS disc (Figure 3.9 B). TPU/PS scaffolds 
fabricated at 55 oC showed that this sample reach an elastic limit upon 
compression and beyond this point permanent damage to the material occurred and 
this profile was an elastic-brittle mechanical properties (Figure 3.9 B).  
 
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
0
20
40
60
80
100
120
140
160 Venting time (sec/min)
TPU/PS disc
60 min
30 min
5 sec
*
(A)
 
 
St
re
ss
 (M
Pa
)
Strain (%)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
0
4
8
12
16
20
24
28 Temperature (oC)
TPU/PS disc
55 oC
45 oC**
(B)
 
 
Strain (%)
St
re
ss
 (M
Pa
)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
0
4
8
12
16
20
24
28
TPU/PS disc
180 min
120 min
*
(C)
 
 
Soakng time (min)
Strain (%)
St
re
ss
 (M
Pa
)
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
0
10
20
30
40
50
60
70
TPU/PS disc
300 bar
200 bar
*
(D)
 
 
Pressure (bar)
Strain (%)
St
re
ss
 (M
Pa
)
Figure 3.9. Compression stress-strain behavior of 3D TPU/PS blends porous 
scaffolds fabricated with various processing conditions, (A): venting time, (B): 
temperature, (C) soaking time and (D): pressure. Star indicated mechanical yield 
point of 2D TPU/PS disc and 3D TPU/PS blend porous scaffolds fabricated at 55 
oC. 
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3.4 Discussion 
 
In this study, 3D TPU/PS blend porous scaffolds were fabricated by scCO2 with 
different processing conditions. TPU and PS are immiscible and when blended, 
two phases, TPU rich phase and PS lean phase, were observed in the 3D TPU/PS 
blend porous scaffolds. The microstructure of 3D TPU/PS blend porous scaffolds 
such as pore size and porosity can be tailored by careful control scCO2 processing 
parameters; and physical properties of 3D TPU/PS blend porous scaffolds such as 
density and modulus rely on micro-architecture fabricated via different scCO2 
processing condition.  
 
The microstructure of 3D TPU/PS blend porous scaffolds formed by scCO2 with 
different processing parameters such as VT, T, ST and P, depends on nucleation, 
density, solubility of scCO2 in the polymeric material and escape rate of scCO2 
from polymeric materials [2, 196, 198].  
 
Reducing pressure from high pressure to ambient environment will generate 
nucleation or bubbles of scCO2 in the samples [196 - 198]. These nuclei grow to 
form the pores in the samples. The fast depressurization rate causes large number 
of nucleation sites to be produced, thus fabricating smaller pore size. A longer 
venting period allows for greater pore growth, therefore larger pores are formed, 
which in turn produced scaffolds with decreased porosity and density [196 - 198]. 
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However, as the pore size increased, the porosity of these samples decreased with 
pore size increasing. In addition, as the 3D TPU/PS blend porous scaffolds 
reached their melting state (TPU: Tg: - 45 oC, Tm: 33.4 oC, DSC data), some of the 
pores would fuse together forming large pores. 
 
In the present study, these results demonstrated that increasing temperature causes 
the pore size and porosity to decrease, while increasing the compression modulus. 
These results differ to those previously reported in that increasing in temperature 
led to increase in pore size [195 - 200]. There were fewer pores formed when 
scaffolds were produced at 55 oC. This could be attributed to pores fabricated at 55 
oC collapse and fuse together at melting state of 3D TPU/PS porous scaffolds. 
 
The data obtained from this study showed that an increase in soaking time 
resulted in scaffolds with large pore size (Figure 3.6 A). This is in contrast to that 
reported by Hongyun Tai et al [198], whereby the pore size of scaffolds decreased 
with increased soaking time. In addition, the porosity and modulus decreased with 
the increase in soaking time. A longer soaking time would enable more CO2 to 
diffuse and distribute into the sample, leading to scaffolds that are more porous 
being formed after venting. However, at the melting state, these pores could 
amalgamate producing large pore size, thus, reducing the porosity of the scaffold. 
As the pore size increased, the modulus of these scaffolds in turn decreased [199, 
200]. 
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Hongyun Tai et al [198] reported that high pressure improved the dissolution of 
CO2 leading to higher nucleation densities and smaller pores [198]. However, the 
present data demonstrated contrary results. This can be attributed to higher 
pressure causing more CO2 dissolution in the matrix but due to its melting state, 
more pores may amalgamate. As a result, scaffolds with larger pore size and 
moderate porosity were fabricated, the modulus of these samples decreased with 
the increase in pressure. 
 
In general, the compressive stress–strain curves for 3D porous scaffolds 
composed of non-brittle polymer material exhibit some distinct characteristics: (1) 
linear elastic deformation at small strain; (2) flexural deformation for the elastic 
material or yielding deformation for the elastic and plastic material at larger strain; 
(3) followed by a plateau region at larger strain and a solidifying region in which 
the stress sharply increases at very large strain [199, 200]. The compression 
stress-strain curves of present study except 3D TPU/PS porous blend scaffolds 
fabricated at 55 oC indicated that all 3D TPU/PS blend porous scaffolds fabricated 
at different parameters display these characteristics and have not shown any 
yielding deformation, indicating that these porous scaffolds possess well-defined 
compressive mechanical properties and excellent elastic properties (Figure 3.12). 
TPU/PS blend scaffolds fabricated at 55 oC showed similar stress-strain to 2D 
TPU/PS disc. This suggested that 3D porous TPU/PS blend scaffolds fabricated at 
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55 oC have microstructure and mechanical properties that were similar to 2D 
TPU/PS disc. 
 
The compression modulus of all 3D TPU/PS blend porous scaffolds fabricated via 
various VT, P and ST decreased as the pore size increased leading to lower 
mechanical strength. This is in accordance with published literature [197]. The 
modulus of 3D TPU/PS blend porous scaffolds fabricated via different 
temperature increased. This was because at high temperature, pores in 3D TPU/PS 
blend porous scaffolds collapsed and fused together, resulting in increased 
modulus. 
 
3.5 Conclusions  
 
3D TPU/PS blend porous scaffolds were fabricated by scCO2 method with 
different processing parameters. The physiochemical, mechanical properties and 
microstructure of TPU/PS scaffolds were investigated. This study demonstrated 
that:  
 
(1) TPU/PS blend were immiscible, producing two phases in 3D TPU/PS blend 
porous scaffolds, which were TPU rich phase and PS lean phase; 
(2) 3D TPU/PS blend porous scaffolds with a variety of pore size and porosity can 
be custom made through careful controlling of scCO2 processing parameters; 
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(3) The mechanical properties of 3D TPU/PS blend porous scaffolds depended on 
the microstructure of the scaffolds; 
(4) 3D TPU/PS blend porous scaffolds exhibited excellent compressive 
mechanical properties and excellent elastic properties with the exception of 3D 
TPU/PS blend porous scaffolds produced at 55 oC.  
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CHAPTER FOUR 
  
4 Interconnectivity Improvement of 3D TPU/PS 
Blend Porous Scaffolds using Solvent Etching 
 
4.1  Introduction 
 
Tissue engineering scaffolds are one of important alternative in regeneration 
medicine as they provide biomimetic structure and mechanical properties of the 
host tissue. Growth factors or gene were coated or entrapped into 3D porous 
scaffolds, and they were transplanted to damaged place or dysfunctional organs to 
guide the cell adhesion, proliferation and regeneration tissues formation via 
controlled release growth factors from scaffolds [1]. Recently, scaffold design has 
become increasingly important for tissue engineering applications because 
scaffold microstructure such as porosity, pore size and interconnectivity 
influences cell attachment, proliferation, controlled release and tissues formation 
[1, 174]. A common drawback of using scaffolds in tissue engineering is the 
limited interconnectivity of scaffolds [171, 173, 176, 177]. Limited 
interconnectivity of scaffolds causes poor nutrient and waste exchange, poor cell 
seeding and infiltration. This will lead to uneven cell distribution, limited tissue 
formation and inflammatory reaction triggered by the degradation product of 
scaffold. Subsequently, these will lead to necrosis and transplant failure. 
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Scaffolds fabricated via scCO2 technology have attracted increased attention in 
the field of tissue engineering because scCO2 is an inexpensive, non-toxicity, 
non-flammable gas and without using chemical solvent in the scaffolds’ 
fabrication [2, 3, 178]. However, scCO2 technology, like the other techniques, 
also fabricates 3D scaffolds with limited interconnectivity and porous surface. In 
order to address these problems, particle leaching has been combined with scCO2 
technology. Although this improves the interconnectivity of scaffolds, the method 
is only applicable to non degradable polymers. This is because biodegradable 
polymeric scaffolds exposed to water or humid environment induce scaffolds 
degradation and decrease mechanical properties prior to their application [1]. The 
use of scCO2 combined with solvent etching, namely, utilizing properties of 
materials with diverse solubilities in different solvents, can address this issue. 
 
In chapter 3, 3D TPU/PS blend porous scaffolds were successfully fabricated via 
scCO2 technology, and two phases were observed in the scaffolds which were TPU 
rich phase and PS lean phase. In this chapter, in order to improve interconnectivity 
of 3D TPU/PS blend porous scaffolds, solvent etching technology was chosen to 
remove PS particles from PS lean phase in the 3D TPU/PS blend porous scaffolds. 
Angélique Léonard et al reported [15] that ideal scaffolds should have pore size 
range from 25 µm to 400 µm and at least 70 % porosity to suit for different kind’s 
cells. 3D TPU/PS blend porous scaffolds fabricated at P = 300 bar, ST = 60 
minutes, T = 35 oC, VT = 60 minutes presents with pore size of 215.7 ± 58.5µm 
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and porosity of 75 ± 4.2 % was chosen to improve interconnectivity via solvent 
etching in this chapter. This scaffold will be used in chapter 5 and 6 to compare the 
influence of different interconnectivity on cell proliferation onto scaffolds and in 
vitro controlled release manner. The interconnectivity and mechanical properties of 
3D TPU/PS blend porous scaffolds before and after solvent etching were 
investigated.  
 
4.2 Materials and Methods 
 
4.2.1 Sample preparation 
 
In this study, 3D TPU/PS blend porous scaffolds fabricated using P = 300 bar, ST 
= 60 minutes, T = 35 oC, VT = 60 minutes presents with pore size of 215.7 ± 58.5 
µm and porosity of 75 ± 4.2 % was chosen to improve interconnectivity via 
solvent etching.  
 
4.2.2 Solvent Etching 
 
Toluene was chosen as the solvent because PS is soluble in it while TPU remained 
insoluble. 3D TPU/PS blend porous scaffolds chosen in this study were put into 
100 ml toluene solution and stirred for 72 hours. Toluene was changed every 24 
hours. After solvent etching, the scaffolds were placed in the fume hood overnight 
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to evaporate the toluene. The morphology, permeability and mechanical properties 
of the samples after solvent etching were assessed. 
 
4.2.3 Permeability and Mechanical Properties Investigation 
 
The permeability of scaffolds before and after solvent etching was calculated using 
Darcy’s Law from the equation 4.1: 
 
K= Qlµ/ΔPA                            (4.1)  
 
where Q is the volumetric flow rate (ml/s), l is the specimen length (m), µ is the 
kinematic fluid viscosity of water (Pa. s), ΔP is the pressure (N/m2), A is the 
specimen cross-sectional area (m2), and K is the permeability (m2). The 
permeability of scaffolds can be used to compare with the pore interconnectivity of 
scaffolds as previously reported [202]. The mechanical properties assessment was 
carried out as Chapter 3.2.1 description.  
 
4.3 Statistics 
 
All data were presented as means ± standard error of means. Statistical analysis 
was performed with SPSS 17.0 package. Statistical comparisons were performed 
using paired-samples t test. P < 0.05 was considered statistically significant.   
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4.4 Results  
 
4.4.1 Morphology Assessment 
 
Figures 4.1 A and B showed images of 3D TPU/PS blend porous scaffolds after 
solvent etching. It can be seen that the PS particles (seen as round particles in 
Figure 4.1 A) were effectively removed from the 3D TPU/PS blend porous 
scaffolds via solvent etching (Figure 4.1 B and C).  
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Figure 4.1. SEM images of 3D TPU/PS blend porous scaffolds fabricated at P = 
300 bar, ST = 60 minutes, T = 35 oC, VT = 60 minutes after solvent etching. A: 
before solvent etching; B and C: after solvent etching. (B and C were taken from 
different areas of 3D TPU/PS blend porous scaffold). Scale bar = 100 µm. 
 
4.4.2 Permeability assessment 
 
Figure 4.2 showed the permeability assessment of 3D TPU/PS blend porous 
scaffolds before and after solvent etching. The permeability of the scaffolds 
improved from 1.63 × 10 -9 m2 to 2.44 × 10 -9 m2 after solvent etching. 
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Figure 4.2. Permeability of 3D TPU/PS blend porous scaffolds fabricated at P = 
300 bar, ST = 60 minutes, T = 35 oC, VT = 60 minutes before and after solvent 
etching. * P < 0.001 compared to before solvent etching group.   
 
4.4.3 Mechanical properties 
 
It can be seen from Figure 4.3 A that the compression stress-strain behaviors of all 
3D TPU/PS blend porous scaffolds exhibit typical properties of elastomeric 
materials before and after solvent etching. These compression stress-strain 
behavior indicated that distinct properties of non-brittle polymer materials such as 
linear elastic deformation at small strain, flexural deformation for the elastic 
materials or yielding deformation for the elastic and plastic materials at larger 
strain, followed by a plateau region at more larger strain and a solidifying region in 
which the stress sharply increases at very large strain [200, 201]. These 
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compression stress-strain curves have not shown any yielding deformation; 
indicated that these porous scaffolds possess well-defined compressive mechanical 
properties and excellent elastic properties. Figure 4.3 B showed that there was not 
change between the storage modulus of 3D TPU/PS blend porous scaffolds, 52.24 
± 5.2 MPa, before solvent etching and 48.5 ± 7.8 MPa, after solvent etching (P > 
0.05).  
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Figure 4.3. (A): compression stress-strain behavior of 3D TPU/PS blend porous 
scaffolds fabricated at P = 300 bar, ST = 60 minutes, T = 35 oC, VT = 60 minutes 
before and after solvent etching; (B): compression modulus of TPU/PS scaffolds 
fabricated at P = 300 bar, ST = 60 minutes, T = 35 oC, VT = 60 minutes before 
and after solvent etching. * P > 0.05 compared to TPU/PS scaffolds before solvent 
etching. 
 
4.5  Discussion 
 
Solvent etching was commonly used to observe phase behavior of polymer blend 
[203]. In this chapter, it was used to improve interconnectivity of 3D TPU/PS 
blend porous scaffolds. The morphology, permeability and mechanical properties 
of 3D TPU/PS blend porous scaffolds before and after solvent were investigated. 
As literature reported [1, 174] that microstructure of scaffolds such as pore size, 
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porosity and interconnectivity is crucial parameters of scaffolds; and the pore size 
and porosity can be tailored using different fabrication technologies to satisfy the 
requirements of tissue engineering application. However, limited scaffold 
interconnectivity is one of the drawbacks that restrict such an application. 
 
It was shown that interconnectivity of 3D TPU/PS blend porous scaffolds were 
improved via solvent etching to removed PS particle from PS lean phase in the 
scaffolds (P < 0.001). The mechanical properties of 3D TPU/PS blend porous 
scaffolds before solvent etching and after solvent etching were kept (P > 0.05). 
These results demonstrated that solvent etching is a new technology and can be 
combined with scCO2 to improve interconnectivity of scaffolds without losing 
mechanical properties of scaffolds.  
 
4.6  Conclusions 
 
Solvent etching improved the interconnectivity of 3D TPU/PS blend porous 
scaffolds while maintaining their mechanical properties. This study has shown the 
following:  
 
(1) PS particles in 3D TPU/PS blend porous scaffolds were successfully 
removed from PS lean phase using solvent etching;  
(2) The interconnectivity of 3D TPU/PS blend porous scaffolds was improved 
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by via solvent etching (P < 0.001);  
(4)  The mechanical properties of 3D TPU/PS blend porous scaffolds after 
solvent etching were maintained (P > 0.05);  
(5) Solvent etching is a new method that can be used to improve 
interconnectivity of 3D TPU/PS blend porous scaffolds effectively.  
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CHAPTER FIVE 
 
5 Biological Assessment of 3D TPU/PS Blend 
Porous Scaffolds  Fabricated via Supercritical 
Carbon Dioxide Combined with Solvent 
Etching 
 
5.1  Introduction 
 
The goal of 3D tissue engineering scaffolds is to develop cells, bioactive 
molecules onto bio-mimic 3D porous structure to replace or restore damaged 
tissue or dysfunctional organ [204 - 206]. Researches indicated that in addition to 
matrix chemistry properties microstructure of 3D porous scaffolds which provide 
a framework for cell adhesion, proliferation, differentiation and form a neo-tissue 
or organ have an outstanding effect on manipulation cell function in tissue 
engineering application [207 - 209]. This is because they provide sufficient 
opportunity for cells to proliferate, and migrate in the 3D porous scaffolds [210 - 
212]. In addition, ideal pore size, porosity and interconnection of the 3D porous 
scaffolds also enable a good exchange of nutrition diffusion，oxygen supply, and 
diffusion of metabolic wastes. [176, 213 - 217]. This in turn encourages more 
cells proliferation and migration in the scaffolds [210 - 212]. Conversely limited 
pore size, porosity and interconnectivity led to poor cell proliferation, migration 
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and differentiation on the scaffolds [176, 213 - 217]. 
 
3D TPU/PS blend porous scaffolds with improved interconnectivity have been 
successfully fabricated via scCO2 combined with solvent etching as described in 
chapters 3 and 4. The aim of this chapter is to evaluate biological properties of 3D 
TPU/PS blend porous scaffolds. The biocompatibility, influence of 
micro-architecture, namely, pore size, porosity and interconnectivity on fibroblast 
cells proliferation into 3D TPU/PS blend porous scaffolds were also investigated. 
 
5.2  Materials and Methods 
 
5.2.1 Samples Preparation  
 
Discs of TPU/PS blend were placed into a 100-ml supercritical fluid extraction 
vessel (Applied separation, USA). The instrument is equipped with pressure 
monitor, temperature and venting controller. The vessel was immediately filled 
with CO2 and heated to a desired T of 35 oC, 45 oC and 55 oC; and then 
pressurized to certain P range form 100 bar, 200 bar and 300 bar; over a desired 
ST of 60 minutes, 120 minutes and 180 minutes. After that the vessel was 
depressurized to ambient pressure with a preset VT of 5 seconds, 30 minutes and 
60 minutes via venting controller. Then, the interconnectivity of all 3D TPU/PS 
blend porous scaffolds were improved via solvent etching. 
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5.2.2 Biocompatibility Assay 
 
Fibroblast cells were cultured in normal culture medium DMEM (Gibco, USA) 
supplemented with 10 % fetal bovine serum (Bovogen Biologicals, VIC, 
Australia), 50 U/ml penicillin and 50 ug/ml streptomycin (Sigma, USA). 
Experiments were conducted with cells from passage 7 - 9 and were incubated at 
37 oC in a humidified environment of 5 % CO2. The MTT assay was used to 
evaluate biocompatibility and cell proliferation on the 3D TPU/PS blend porous 
scaffolds. The fibroblast cells were seeded into a 12-well tissue culture plate at a 
density of 1×104 cells per well in a total volume of 1 ml. After 24 hours post 
seeding, the polymeric discs of TPU/PS blend scaffolds were placed into culture 
inserts with 0.4 μm pore size (Falcon, BD Biosciences, NJ, USA), which were 
then attached onto the fibroblast cells-seeded wells and incubated for 3 days at 
37 °C in 5 % CO2. Seeded wells without 3D TPU/PS blend porous scaffolds were 
as positive control referred to as TCPS. After 3 days, the samples were removed 
and wells were washed twice with PBS to remove non-attached cells. Briefly, 500 
µl of phenol red free RPMI (Gibco, Invitrogen, Australia) were added to each well, 
followed by 50 µl of 5 mg/mL of MTT. The samples were incubated at 37 oC for 4 
hours. The concentration of the solution was measured at a wavelength of 570 nm 
with a reference range of 690 nm using a microplate reader (GENios pro, Tecan, 
NC, USA).  
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5.2.3 Cell Morphology 
 
The scaffolds were placed individually into 12-well tissue culture polystyrene 
plates (Iwaki, Interpath Services, VIC, Australia). Fibroblast cells were 
trypsinized in 0.1 % Trypsin in 5 mM EDTA solution and seeded onto the 3D 
TPU/PS blend porous scaffolds and 2D TPU/PS disc at a density of 1 × 104 
cells/disc. The seeded samples were incubated at 37 °C in a humidified 
environment of 5 % CO2 for 3 days. After 3 days all samples were rinsed briefly 
with PBS and stained with DAPI and Alexa Fluor 568 (Molecular Probe, 
Invitrogen, CA, USA). Confocal microscope (Leica, SP5, Germany) was used to 
assess fibroblast morphology.  
 
5.3 Statistics   
 
All date were presented as means ± standard error of means. Statistical analysis 
was performed with SPSS 17.0 package. Statistical comparisons were performed 
using paired-samples t test. P < 0.05 was considered statistically significant. 
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5.4 Results 
 
5.4.1 Biocompatibility and Cell Morphology of 3D TPU/PS    
Blend Porous Scaffolds 
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Figure 5.1. Biocompatibility assessment of 3D TPU/PS blend porous scaffolds 
fabricated via scCO2 with different parameters after solvent etching.   
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Figure 5.2. Confocal images of fibroblast cells growth on the 3D TPU/PS blend 
porous scaffolds via different processing parameters, (A): VT = 5 seconds, (B): 
VT = 30 minutes, (C): VT = 60 minutes, (D): T = 45 oC, (E): T = 55 oC, (F): ST = 
120 minutes, (G): ST = 180 minutes, (H): P = 200 bar, (I): P = 300 bar and (J): 2D 
TPU/PS disc. Scale bar = 100 μm. 
 85
Figure 5.1 showed that the viability of cells cultured on all 3D TPU/PS blend 
porous scaffolds was over 80 % as compared to the TCPS group. The morphology 
of fibroblast cells seeded on the 3D TPU/PS blend porous scaffolds fabricated via 
different processing conditions was observed via confocal microscope. As shown 
in Figures 5.2 from A to I, with the exception of E and J, after 3 days of culture, 
the fibroblast cells had attached and proliferated throughout the scaffolds. This 
can be seen by the fibroblast cells proliferation around the pores, forming circular 
patterns. Figure 5.2 E showed that fibroblast cells seeded onto 3D TPU/PS blend 
porous scaffolds fabricated via 55 oC had similar growth pattern, attachment and 
spread cross the surface with fibroblast cells growth onto 2D TPU disc (Figure 5.2 
I). This could be attributed to scaffolds produced at 55 oC having similar surface 
structure as the 2D disc, in that; there are no pores on these scaffolds. 
 
5.4.2 Effect of Pore Size and Porosity on Cell Growth 
 
Fibroblast cells growth on 3D TPU/PS blend porous scaffolds fabricated via 
different parameters with various pore size and porosity with improved 
interconnectivity are listed in Table 5.1.  
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Figure 5.3. Cell number on 3D TPU/PS blend porous scaffolds fabricated using 
different venting time with different pore size (A) and porosity (B). 
 
It can be seen from Figures 5.3 A and B and Table 5.1 that increasing pore size 
from 40.5 ± 16.8 µm, 104.3 ± 38.2 µm to 259 ± 81.6 µm, the cell number 
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adhesion and proliferation on the scaffolds decrease from 7494 ± 562, 5198 ± 748 
to 4398 ± 296. Also with porosity decrease from 81 ± 7.23 %, 75.6 ± 4.1 % to 
43.6 ± 2.1 %, the cell number adhesion and proliferation on the scaffolds decrease 
from 7494 ± 562, 5198 ± 748 to 4398 ± 296.  
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Figure 5.4. Cell number on 3D TPU/PS blend porous scaffolds fabricated using 
different temperature with different pore size (A) and porosity (B). 
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Cells cultured on the 3D TPU/PS blend porous scaffolds fabricated via different 
temperature with variety of pore size and porosity were shown in Table 5.1 and 
Figures 5.4 A and B. The 3D TPU/PS blend porous scaffolds fabricated at 55 oC 
displayed similar cell number when compared to 2D TPU/PS discs. The cell 
growth was the highest on the 3D TPU/PS blend porous scaffolds fabricated at 
45oC, with 6298 ± 524 cells over 3 days.  
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Figure 5.5. Cell number on 3D TPU/PS blend porous scaffolds fabricated using 
different soaking time with different pore size (A) and porosity (B). 
 
It can be seen from Table 5.1 and Figures 5.5 A and B that 3D TPU/PS blend 
porous scaffolds fabricated at different soaking times had the similar cell 
proliferation pattern as TPU/PS blend scaffolds fabricated with various venting 
times. 3D TPU/PS blend porous scaffolds produced via 120 minutes soaking time 
had smaller pore size and higher porosity than scaffolds fabricated using 180 
minutes soaking time. There were 26 % more cells attached onto scaffolds 
fabricated with 120 minutes soaking time than on those produced via 180 minutes 
soaking time.  
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Figure 5.6. Cell number on 3D TPU/PS blend porous scaffolds fabricated using 
different pressures with different pore sizes (A) and porosities (B). 
 
Table 5.1, Figures 5.6 A and B clarified that cell number proliferation on 3D 
TPU/PS blend porous scaffolds fabricated with different pressure. It can be seen 
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from Figure 5.6 A and Table 5.1 that with the pressure increase from 200 bar to 
300 bar the pore size increased from 96.9 ± 37.2 to 215.7 ± 58.5 µm and porosity 
decreased from 80.4 ± 3.1 to 75 ± 4.2 % the cell number decreased from 9981 ± 
449 to 7895 ± 614.  
 
5.4.3 Effect of Interconnectivity on Cell Growth 
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Figure 5.7. Cell number on 3D TPU/PS blend porous scaffolds before and after 
solvent etching. * P< 0.001 compared to cell number proliferation on 3D TPU/PS 
blend porous scaffolds before solvent etching treatment. 
 
Difference of cell proliferation on the 3D TPU/PS blend porous scaffolds before 
and after solvent etching was observed from Table 5.1 and Figure 5.7. Cell 
proliferation on the 3D TPU/PS blend porous scaffolds after solvent etching 
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improved with the number of cell increasing from was 4982 ± 1345 before solvent 
etching to 7895 ± 614 (P < 0.001). 
 
5.5  Discussion 
 
In this chapter, the biocompatibility assessment of 3D TPU/PS blend porous 
scaffolds showed excellent cell viability. All 3D TPU/PS blend porous scaffolds 
demonstrated cell viability of over 80 % compared to the TCPS group (Figure 5.1). 
It is widely accepted that good biocompatibility is defined as cell viability over 
70 % compared with controlled group [218]. No residual chemical solvent and 
toxicity were observed in the 3D TPU/PS blend porous scaffolds indicating that 
the chemical solvent used to fabricate 3D TPU/PS blend porous scaffolds were 
successfully eliminated during the manufacturing process. Cell morphology 
depicted by confocal microscopy images, in conjunction with the cell viability data 
indicated that 3D TPU/PS blend porous scaffolds have excellent biocompatibility. 
 
Microstructure of scaffolds such as pore size, porosity and degree of 
interconnectivity are important factors that influence cell attachment and 
proliferation, subsequent tissue regeneration and development [171, 176]. The 
MTT results indicated that there were more cells proliferating on 3D TPU/PS 
blend porous scaffolds than the nonporous 2D TPU/PS discs. This was due to the 
3D TPU/PS blend porous scaffolds providing a larger surface area for cell 
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adhesion and growth. In addition, as shown in Figures 5.3, 5.5 and 5.6, the MTT 
results demonstrated that with the increase in pore size, the cell number 
proliferation on the porous scaffolds decreased, while decreasing porosity the cell 
number growth on the scaffolds decreased. This influence might be attributed to 
lower mean pore size with higher porosity, resulting in higher surface area, and 
this may allow more proteins from the culture media to be absorbed onto scaffolds. 
It provides a more conducive environment for cell attachment and proliferation. 
This result is in agreement with the results previously reported by others that with 
pore size decrease the amount of fibroblast cell attachment increase [219]. 
 
It has been showed that limited interconnectivity and limited oxygen supply, along 
with metabolic waste accumulation restrict cell migration and proliferation to the 
center of scaffolds [175, 177]. This generally resulted in decreased cell 
proliferation on the scaffolds. Such a scaffold will lead to necrotic formation 
within the scaffolds and subsequent transplant failure should it be used for tissue 
regeneration [178, 180]. Data of this study showed that improved interconnectivity 
of 3D TPU/PS blend porous scaffolds has significant influence on fibroblast cells 
adhesion and proliferation on these scaffolds. Prior to solvent etching, the 
interconnectivity of scaffolds were lower, leading to limited nutrition and oxygen 
supply, and metabolic waste accumulating in the scaffolds [175, 177]. This was 
demonstrated by the lower cell number proliferation observed on 3D TPU/PS 
blend porous scaffolds before solvent etching (Figure 5.7). After solvent etching, 
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the interconnectivity of the 3D TPU/PS scaffolds was improved (Chapter 4). This 
led to the cell number proliferation on 3D TPU/PS blend porous scaffolds being 
higher than those culturing on the 3D TPU/PS blend porous scaffolds before 
solvent etching. The increase in cell number was most likely due to the enhanced 
interconnectivity providing more volume and inner surface to improve fibroblast 
cells attachment and growth. Furthermore, good interconnectivity also allows 
more nutrition and oxygen to infiltrate the entire scaffold, and effective means of 
waste exchange. This enabled cells to distribute and proliferate throughout the 
scaffolds.  
 
6.3 Conclusions 
 
In this chapter, fibroblast cells were seeded onto 3D TPU/PS blend porous 
scaffolds. The biocompatibility assessment and the influence of microstructure of 
3D TPU/PS blend porous scaffolds on fibroblast cells growth were evaluated. The 
results obtained have demonstrated the following:  
  
(1)  All 3D TPU/PS blend porous scaffolds fabricated via different processing 
conditions have excellent biocompatibility.  
(2)  Pore size and porosity have significant effect on the biological capability 
of 3D TPU/PS blend porous scaffolds. The fibroblast cell attachment and 
proliferation on 3D TPU/PS blend porous scaffolds decreased with the           
 96
increase in pore size and decrease in porosity. 
(3)  The interconnectivity of 3D TPU/PS blend porous scaffolds has a 
significant influence on fibroblast cells adhesion and proliferation on 3D 
TPU/PS blend porous scaffolds. Improved interconnectivity of TPU/PS 
blend scaffolds enabled more cells to adhere and proliferate on 3D 
TPU/PS blend porous scaffolds than on those with limited 
interconnectivity. 
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CHAPTER SIX 
 
6 In vitro Controlled Release Assessment of 
Aspirin Coated 3D TPU/PS Blend Porous 
Scaffolds 
 
6.1  Introduction 
 
The aim of tissue engineering is to replace or facilitate the regrowth of damaged 
or dysfunctional tissue by applying the combination of biomaterials, bioactive 
molecules and cells [161, 220 - 225]. Controlled release of bioactive compounds 
from the 3D porous scaffolds to the local tissue to facilitate tissue regeneration 
becomes one of the important tasks in tissues engineering scaffolds application 
[226 - 227]. This is because controlled release bioactive compounds to the local 
tissue provide the possibility of release bioactive compounds over longer release 
period and higher concentration to facilitate cell proliferation, regeneration tissue 
formation. This is also avoiding side reaction and/or toxic reaction of systemic 
administration [226 - 227].  
 
A variety of methods have been investigated to combine bioactive compounds and 
scaffolds such as absorption or encapsulating of growth factors, protein and gene 
into natural or synthetic polymeric scaffolds during fabrication process to allow 
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local delivery [229 - 231]. However, these manufacturing procedures were not 
suitable for combining these bioactive compounds because elevated temperatures, 
organic solvents, high-pressured gas, vigorous mechanical agitation and particle 
leaching step were commonly used in the processes [232 - 236]. These drawbacks 
can lead to the loss or reduction in the amount and activity of these bioactive 
compounds [237, 237].  
 
In 3D porous scaffolds, the higher the porosity the greater the availability for 
storing bioactive compounds in 3D porous scaffolds. This is due to the increase in 
surface area to volume ratio in these scaffolds. Therefore, it is hypothesized that 
honeycomb structure of 3D porous scaffolds can be used as a reservoir to store 
bioactive compounds and as matrix for in vitro controlled release. Coating 
bioactive compounds onto honeycomb structure would avoid these barriers 
mentioned above.  
 
ASA or aspirin, one of the oldest commercialised medicines still in use, was 
synthesised in 1853. In the past decade aspirin has been most widely studied and 
used as an antiplatelet medicine. [238 - 240].  
 
In this chapter, bioactive molecular such as aspirin was coated onto 3D TPU/PS 
blend porous scaffolds with different microstructures for in vitro controlled 
release assessment. The aims of this study were to  examine the controlled 
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release profiles of aspirin coated 3D TPU/PS blend porous scaffolds with different 
pore sizes, porosities and improved interconnectivity;  investigate the controlled 
release behaviors of different concentrations of aspirin coated onto 3D TPU/PS 
blend porous scaffolds.  
 
6.2  Materials and Methods 
 
6.2.1 Scaffolds Preparation 
 
Discs of TPU/PS blend were placed into a 100-ml supercritical fluid extraction 
vessel (Applied separation, USA). The instrument is equipped with pressure 
monitor, temperature and venting controller. The vessel was immediately filled 
with CO2 and heated to a desired T of 35 oC, 45oC and 55 oC; and then pressurized 
to certain P range form 100 bar, 200 bar and 300 bar; over a desired ST of 60 
minutes, 120 minutes and 180 minutes. After that the vessel was depressurized to 
ambient pressure with a preset VT of 5 seconds, 30 minutes and 60 minutes via 
venting controller. Then, the interconnectivity of all 3D TPU/PS blend porous 
scaffolds were improved via solvent etching as chapters 3 and 4 descriptions. 
 
6.2.2 Aspirin Coating on 3D TPU/PS Blend Porous Scaffolds 
 
All 3D TPU/PS blend porous scaffolds were immersed into vials that contained 
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aspirin solution ranging from 10 mg/ml to 50 mg/ml in neat ethanol for 24 hours 
at room temperatures. To ensure thorough aspirin afflux into the 3D TPU/PS blend 
porous scaffolds, the vials were placed into vacuum chamber to remove bubbles in 
the scaffolds. After that, the scaffolds were placed in the fume hood for 24 hours 
to evaporate off the ethanol. 
 
6.2.3 Measurement of Aspirin Coated on 3D TPU/PS Blend 
Porous Scaffolds 
 
The amount of aspirin coated onto the 3D TPU/PS blend porous scaffolds were 
measured by immersing the aspirin-loaded scaffolds in PBS solution. These vials 
were stored in the dark at 37 oC. At prearrangement interval 1ml PBS was 
removed from each vial and analyzed by UV spectrophotometer at 296 nm. 
Standard curves were prepared for each concentration in the PBS so that the 
absorbance could be converted to concentrations using the Lambert-Bear Law 
[241].  
 
6.2.4 Effect of Microstructure on In Vitro Release 
 
To evaluate the effect of microstructures such as pore size, porosity and 
interconnectivity on in vitro controlled release of the 3D TPU/PS blend porous 
scaffolds, aspirin was coated on all 3D TPU/PS blend porous scaffolds and the 
 101
release profiles were measured, as described above in 6.2.2 and 6.2.3 respectively.  
 
6.2.5 Effect of Concentration of Aspirin on In Vitro Release 
 
In order to assess the in vitro controlled release manner of different concentrations 
of aspirin coated on 3D TPU/PS blend porous scaffolds, 3D TPU/PS blend porous 
scaffolds with 215.7 ± 58.5 µm pore size and 75 ± 4.2 % porosity was chosen for 
this experiment as described at chapter 4. 3D TPU/PS blend porous scaffolds 
coated with different concentrations of aspirin from 10 mg/ml, 20 mg/ml, 30 
mg/ml, 40 mg/ml to 50 mg/ml were used and the amount released over 14 Days 
were measured via UV spectrophotometer at 296 nm.  
 
6.3  Statistics 
 
All date were presented as means ± standard error of means. Statistical analysis 
was performed with SPSS 17.0 package. Statistical comparisons were performed 
using paired-samples t test. P < 0.05 was considered statistically significant. 
 
6.4  Results 
 
Table 6.1 and Figures 6.1 to 6.4 exhibited in vitro controlled release behavior of 
aspirin coated 3D TPU/PS blend porous scaffolds produced at various scCO2 
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processing conditions with variety of pore size, porosity and after solvent etching 
processing. All of the in vitro release behaviors of aspirin coated 3D TPU/PS 
blend porous scaffolds demonstrated a classical “ S ” release profile with the 
exception of scaffolds fabricated at 55 oC (Figures 6.2 A and B). “ S ” release 
manner indicated that bioactive molecular entrapped into scaffolds was uniform; 
bioactive compounds released from scaffolds with slower and steady pattern. It 
can be seen from Figures 6.1 to 6.4 that there is no burst release from these 
scaffolds on Day 1. The difference between release time, release amount and 
microstructure of 3D TPU/PS blend porous scaffolds were observed. As the pore 
size increased and porosity decreased, the maximum amount released and the time 
for the release decreased with the exception of TPU/PS scaffolds fabricated at 55 
oC.  
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6.4.1 In Vitro Aspirin Release Behavior on 3D TPU/PS Blend 
Porous Scaffolds with Difference Pore Size and Porosity 
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Figure 6.1. In vitro controlled release behavior of 3D TPU/PS blend porous 
scaffolds fabricated via different venting time (■: 5 seconds, ●: 30 minutes and 
▲: 60 minutes) with different pore size (A) and porosity (B).  
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Table 6.1 and Figure 6.1 showed the in vitro controlled release behavior of 3D 
TPU/PS blend porous scaffolds fabricated with different venting time from 5 
seconds, 30 minutes to 60 minutes. It can be seen from Table 6.1, Figures 6.1 A 
and B that with the increase in pore size from 40.5 ± 16.8 µm, 104.3 ±38.2 µm to 
259 ± 81.6 µm the maximum time of in vitro release decreases from 13 days, 7 
days to 6 days. With porosity decrease from 81 ± 7.23 %, 75.6 ± 4.1 % to 43.6 ± 
2.1 %, the similar trends were observed. The maximum amount of in vitro release 
also decreased from 1.48 mg, 0.40 mg to 0.26 mg. 
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Figure 6.2. In vitro controlled release behavior of 3D TPU/PS blend porous 
scaffolds fabricated via different temperature (■: 45 oC and ●: 55 oC) with 
different pore size (A) and porosity (B). 
 
The in vitro controlled release behavior of 3D TPU/PS blend porous scaffolds 
fabricated with different temperature, 45 oC and 55 oC, are shown in Table 6.1 and 
Figure 6.2. It can be seen from Figures 6.2 A and B that there was a burst release 
in the first 4 hours and then a decrease in the amount of aspirin released from 
TPU/PS blend porous scaffolds fabricated at 55 oC. The maximum amount of 
release in this scaffold was 0.16 mg. The release time and release amount of 3D 
TPU/PS blend porous scaffolds fabricated at 45 oC was up to 7 days and 0.86 mg. 
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Figure 6.3. In vitro controlled release behavior of 3D TPU/PS blend porous 
scaffolds fabricated by different soaking time (■: 120 minutes and ●: 180 
minutes) with different pore size (A) and porosity (B). 
 
In vitro controlled release behavior of 3D TPU/PS blend porous scaffolds 
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fabricated with different soaking time, 120 minutes and 180 minutes, was looked 
at Table 6.1 and Figures 6.3 A and B. The maximum amount of release in 3D 
TPU/PS blend porous scaffolds fabricated at different soaking time decreased 
from 9 days to 7 days with pore size increase from 70.1 ± 20.2 µm to 90.6 ± 27.8 
µm and porosity decrease form 70.7 ± 6.3 % to 66 ± 3.6 %. Meanwhile the 
maximum release amount of aspirin reduced from 1.03 mg and 0.52 mg.  
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Figure 6.4. In vitro controlled release behavior of 3D TPU/PS blend porous 
scaffolds fabricated using different pressure (■: 200 bar and ●: 300 bar) with 
different pore size (A) and porosity (B). 
 
As seen from Table 6.1, Figures 6.4 A and B, the maximum amount released and 
release time of 3D TPU/PS blend porous scaffolds fabricated using pressure of 
200 bar was 1.20 mg and 10 days with pore size 96.9 ± 37.2 µm and porosity 80.4 
± 3.1 %. Increasing pressure to 300 bar led to increased pore size to 215.7 ± 
58.5µm and decreased porosity to75 ± 4.2 %. This led to maximum release 
amount and release time decreased to 0.74 mg and 6 days respectively.  
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6.4.2  Effect of Interconnectivity of In Vitro Release 
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Figure 6.5. In vitro controlled release behavior of 3D TPU/PS blend porous 
scaffolds before and after solvent etching. 
 
In vitro controlled release behavior of 3D TPU/PS blend porous scaffolds 
fabricated at T: 35 oC, VT: 60 minutes, ST: 60 minutes, P: 300 bar before and after 
solvent etching was shown in Figure 6.5 and Table 6.1. It can be seen that in 
scaffolds without solvent etching, an increase in the release of aspirin occurred in 
24 hours. This was followed by a slow release up to 4 days and then a decrease. 
After solvent etching, the in vitro release profile showed a gradual release of 
aspirin, peaking at 6 days after which the release plateaued at 0.74mg/ml for at 
least 14 days. The burst release that was observed in the scaffolds without solvent 
etching was not evident in scaffolds that underwent solvent etching. The 
maximum amount of aspirin released from the 3D TPU/PS blend porous scaffolds 
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before and after solvent etching were 0.56 mg/mL and 0.74 mg/mL, respectively 
(P< 0.05 and P< 0.001 compared to 3D TPU/PS blend porous scaffolds before 
solvent etching treatment).  
 
6.4.3 In Vitro Release Manner of Different Concentration 
Aspirin Coated on 3D TPU/PS Blend Porous Scaffolds 
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Figure 6.6. In vitro releases of different concentrations of aspirin from 3D 
TPU/PS blend porous scaffolds after solvent etching. 
  
In vitro controlled release manner of different concentrations of aspirin coated 
onto 3D TPU/PS blend porous scaffolds with improved interconnectivity was 
showed in Figure 6.6. It can be seen from Figure 6.6 that these graphs had similar 
slow and steady release pattern up to 6 days then decreased. Maximum release 
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amount was slight difference range from 0.706 mg, 0.743 mg, 0.744 mg, 0.759 
mg to 0.792 mg. This is due to different concentrations aspirin coated onto 
scaffolds. It can be seen from Figure 6.6 that there are no burst release from these 
scaffolds coated with different concentrations of aspirin on Day 1. 
 
6.5  Discussion 
 
In this chapter, aspirin was successfully coated onto 3D TPU/PS blend porous 
scaffolds. The influence of pore size, porosity and interconnectivity of TPU/PS 
blend porous scaffolds on in vitro release of aspirin was assessed. The effect of 
different content of aspirin coated onto TPU/PS blend scaffolds on in vitro release 
profile was investigated also.  
 
The pore size and porosity have significant influence on the release time and 
amount of release. The smaller pore size and the higher porosity provide the 
scaffolds with higher inner surface area [242 - 244]. This allows more aspirin to 
be coated on the 3D TPU/PS blend porous scaffolds and last longer release time 
and higher release amount. Scaffolds with larger mean pore size and lower 
porosity have lower surface area into scaffolds so less aspirin was coated onto 3D 
TPU/PS blend porous scaffolds, and led to lower release amount and shorter 
release time. 
 
 113
Normally, bioactive compounds controlled release from polymeric 3D porous 
scaffolds via two different approaches. First of all, the bioactive compounds 
diffuse through the porous scaffolds as the porous matrix taken on liquid from 
their ambience. This causes the most bioactive compounds loaded on the surface 
of scaffolds to be washed out referred to as the burst release phase. The burst 
release phase is followed by a gradual release of the remaining bioactive 
compounds [228]. In this in vitro release study, the burst release phase was not 
observed in any of the 3D TPU/PS blend porous scaffolds with the exception of 
those fabricated via at 55 oC (Figures 6.2 A and B) and scaffolds without solvent 
etching treatment (Figure 6.5). This demonstrated that the aspirin coated onto 3D 
TPU/PS blend porous scaffolds was homogeneous. The release profile suggested 
that the initial release of aspirin was from the surface of the scaffolds [241]. This 
was followed by the gradual diffusion from the center of the scaffolds. Such a 
release behavior could be due to the honeycomb microstructure with improved 
interconnectivity of the scaffolds. 
 
Interconnectivity is a factor that plays an important role in the release of bioactive 
compounds from 3D porous scaffolds [243]. 3D TPU/PS blend porous scaffolds 
after solvent etching showed that more loading amount and longer release time 
than 3D TPU/PS blend porous scaffolds before solvent etching. After solvent 
etching, loading amount and release period of aspiring increase 32% and 50% 
respectively. This is due to the solvent etching improving interconnectivity of the 
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scaffolds, thus, providing increased volume and permeability than those before 
solvent etching [245]. This lead to more aspirin coated onto 3D TPU/PS blend 
porous scaffolds.  
 
The release profile of different concentrations of aspirin coated onto 3D TPU/PS 
blend porous scaffolds showed similar release manner and slight discrepancy in 
release amount. This illustrated that in vitro release manner of different 
concentrations aspirin coated onto 3D TPU/PS blend porous scaffolds relied on 
both concentration of aspirin coated onto the 3D TPU/PS blend porous scaffolds 
and microstructure of 3D TPU/PS blend porous scaffolds, pore size, porosity and 
interconnectivity.  
 
6.6  Conclusions 
 
Microstructure of 3D porous scaffolds such as pore size, porosity and 
interconnectivity influences controlled release manner of bioactive compound 
from scaffolds. In present chapter, controlled release behavior of aspirin coated 
onto 3D TPU/PS blend porous scaffolds with difference pore size, porosity, 
interconnectivity; and difference coating concentrations was investigated. 
Conclusions are as follows: 
 
(1) In vitro controlled release behavior of aspirin coated onto 3D TPU/PS 
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blend porous scaffolds with different pore size, porosity and improved 
interconnectivity showed that they significantly influenced the release of 
aspirin. Scaffolds with small pore size, higher porosity and higher 
interconnectivity released larger amount and last longer release time. 
(2)  The interconnectivity of 3D TPU/PS blend porous scaffolds has a 
significant influence on controlled release manner. Improved 
interconnectivity of TPU/PS blend scaffolds enabled large release amount 
(P< 0.05) and longer release time (P < 0.001) than on those with limited 
interconnectivity. 
(3) 3D TPU/PS blend porous scaffolds coated with different concentrations of 
aspirin exhibited similar release profile. The release behavior is 
concentration dependent and is influenced by the microstructure of 
scaffolds also.  
(4) Honeycomb microstructure of 3D TPU/PS blend porous scaffolds can serve 
as a reservoir to store bioactive compound and has the potential to be used 
as a controlled release matrix in drug delivery.   
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CHAPTER SEVEN 
 
7 Conclusions and Recommendations for Future 
Work 
 
7.1  Conclusions 
 
Fabrication and Characterization of 3D Porous 
Thermoplastic Polyurethane/Polystyrene Blend Scaffolds via 
Supercritical Carbon Dioxide 
 
3D TPU/PS blend porous scaffolds with variety of pore size and porosity can be 
tailored by carefully control processing parameters of scCO2. TPU/PS blend are 
immiscible and there are two phases in 3D TPU/PS blend porous scaffolds, which 
are TPU rich phase and PS lean phase. The mechanical properties of 3D TPU/PS 
blend porous scaffolds depend on the microstructure of 3D TPU/PS blend porous 
scaffolds. 3D TPU/PS blend porous scaffolds exhibit excellent compressive 
mechanical properties and excellent elastic properties except 3D porous TPU/PS 
blend scaffolds developed at 55 oC.  
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Improve Interconnectivity of 3D TPU/PS Blend Porous 
Scaffolds using Solvent Etching 
 
PS particles in 3D TPU/PS blend porous scaffolds were successfully removed 
from PS lean phase using solvent etching. The interconnectivity of 3D TPU/PS 
blend porous scaffolds was improved via solvent etching (P < 0.001). The 
mechanical properties of 3D TPU/PS blend porous scaffolds after solvent 
etching were kept (P > 0.05). Solvent etching is new methods to improve 
interconnectivity of 3D TPU/PS blend s porous scaffolds.  
 
Biological Assessment of 3D TPU/PS Blend Porous Scaffolds 
Fabricated via Supercritical Carbon Dioxide Combined with 
Solvent Etching 
 
All 3D TPU/PS blend porous scaffolds fabricated via different processing 
conditions have excellent biocompatibility. Pore size and porosity have significant 
effect on the biological capability of 3D TPU/PS blend porous scaffolds. With 
pore size increase and porosity decrease, fibroblast cells attachment and 
proliferation onto 3D TPU/PS blend porous scaffolds decrease. The 
interconnectivity of 3D TPU/PS blend porous scaffolds has important influence 
on fibroblast cells adhesion and proliferation onto 3D TPU/PS blend porous 
scaffolds. Improved interconnectivity of TPU/PS blend scaffolds has higher cell 
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number adhesion and proliferation on 3D TPU/PS blend porous scaffolds than 
those with limited interconnectivity (P < 0.001). 
 
In vitro Controlled Release Assessment of Aspirin Coated on 
the 3D TPU/PS Blend Porous Scaffolds 
 
In vitro controlled release behavior of aspirin coated onto 3D TPU/PS blend 
porous scaffolds with different pore size, porosity and improved interconnectivity 
showed that they significantly influenced the release of aspirin. Scaffolds with 
small pore size, higher porosity and higher interconnectivity released larger 
amount and last longer release time. The interconnectivity of 3D TPU/PS blend 
porous scaffolds has a significant influence on controlled release manner. 
Improved interconnectivity of TPU/PS blend scaffolds enabled large release 
amount (P< 0.05) and longer release time (P < 0.001) than on those with limited 
interconnectivity. 3D TPU/PS blend porous scaffolds coated with different 
concentrations of aspirin exhibited similar release profile. The release behavior is 
concentration dependent and is influenced by the microstructure of scaffolds also.  
Honeycomb microstructure 3D TPU/PS blend porous scaffolds can serve as a 
reservoir to store bioactive compound and has the potential to be used as a 
controlled release matrix in drug delivery. 
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7.2  Recommendations for Future Work 
 
In vitro and In Vivo Biological Assessment of 3D TPU/PS 
Blend Porous Scaffolds 
 
The results from present study demonstrated that 3D TPU/PS blend porous 
scaffolds with moderate pore size, porosity and with improved interconnectivity 
can be used as candidate matrix in tissue engineering application. The in vitro 
biological assessment showed that all 3D TPU/PS blend porous scaffolds had 
excellent biocompatibility; and fibroblast seeded onto the 3D TPU/PS blend 
porous scaffolds well spread on the both side of pores and inside of pores. 
Honeycomb structure of 3D TPU/PS blend porous scaffolds can be used as 
reservoir in controlled release. 
 
Further work will focus on  in vitro bioactive assessment of aspirin (antiplatelet) 
controlled release from 3D TPU/PS porous scaffolds using human or animal blood 
samples; ⑵ in vivo characterisation of application of 3D TPU/PS blend porous 
scaffolds coated with protein and/or growth factors to stimulate host cell 
proliferation and neo-tissue formation. 
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